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Problem alcohol use is common among illicit drug users and is associated with adverse health outcomes. It is also an
important factor in poor prognosis among drug users with hepatitis C virus (HCV) as it impacts on progression to hepatic
cirrhosis or opiate overdose in opioid users.
Objectives
To assess the effects of psychosocial interventions for problem alcohol use in illicit drug users (principally problem drug
users of opiates and stimulants).
Search methods
We searched the Cochrane Drugs and Alcohol Group trials register (November 2011), the Cochrane Central Register of
Controlled Trials (CENTRAL) (The Cochrane Library, Issue 11, November 2011), PUBMED (1966 to 2011); EMBASE (1974
to 2011); CINAHL (1982 to 2011); PsycINFO (1872 to 2011) and reference list of articles. We also searched: 1) conference
proceedings (online archives only) of the Society for the Study of Addiction (SSA), International Harm Reduction Association
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(IHRA), International Conference on Alcohol Harm Reduction (ICAHR), and American Association for the Treatment of
Opioid Dependence (AATOD); 2) online registers of clinical trials, Current Controlled Trials (CCT), Clinical Trials.org, Center
Watch and International Clinical Trials Registry Platform (ICTRP).
Selection criteria
Randomised controlled trials comparing psychosocial interventions with another therapy (other psychosocial treatment,
including non-pharmacological therapies or placebo) in adult (over the age of 18 years) illicit drug users with concurrent
problem alcohol use.
Data collection and analysis
Two review authors independently assessed risk of bias and extracted data from included trials.
Main results
Four studies, 594 participants, were included. Half of the trials were rated as having high or unclear risk of bias. They
considered six different psychosocial interventions grouped into four comparisons: (1) cognitive-behavioural coping skills
training versus 12-step facilitation (N = 41), (2) brief intervention versus treatment as usual (N = 110), (3) hepatitis health
promotion versus motivational interviewing (N = 256), and (4) brief motivational intervention versus assessment-only group
(N = 187). Differences between studies precluded any pooling of data. Findings are described for each trial individually:
comparison 1: no significant difference; comparison 2: higher rates of decreased alcohol use at three months (risk ratio (RR)
0.32; 95% confidence interval (CI) 0.19 to 0.54) and nine months (RR 0.16; 95% CI 0.08 to 0.33) in the treatment as usual
group; comparison 3 (group and individual format): no significant difference; comparison 4: more people reduced alcohol use
(by seven or more days in the past 30 days at 6 months) in the brief motivational intervention compared to controls (RR 1.67;
95% CI 1.08 to 2.60).
Authors' conclusions
Very little evidence exists that there is no difference in the effectiveness between different types of interventions and that
brief interventions are not superior to assessment only or treatment as usual. No conclusion can be made because of the
paucity of the data and the low quality of the retrieved studies.
Plain language summary
Which talking therapies (counselling) work for drug users with alcohol problems?
What is problem alcohol use and what are psychosocial interventions?
Problematic use of alcohol means drinking above the recommended safe drinking limits. It can lead to serious alcohol
problems or dependence. Excessive drinking in people who have problems with other drugs is common and often makes
their problems worse as well as having serious health consequences for the person involved.
Psychosocial interventions are talking therapies that aim to identify an alcohol problem and motivate an individual to do
something about it. They can be performed by staff with training in these approaches, for example doctor, nurse, counsellor,
psychologist, etc. Talking therapies may help people cut down their drinking but the impact is not known in people who have
problems with other drugs.
We wanted to do a review to see whether talking therapies have an impact on alcohol problems in drug users. In this review,
we wanted to evaluate information from randomised trials in relation to the impact of talking therapies on alcohol drinking in
adult (over the age of 18 years) users of illicit drugs (mainly opiates and stimulants).
This review found the following studies, and came to the following conclusions:
We found four studies that examined 594 people with drug problems. One study looked at cognitive-behavioural coping skills
training versus 12-step facilitation. One study looked at brief intervention versus treatment as usual. One study looked at
motivational interviewing (group and individual format) versus hepatitis health promotion. The last study looked at brief
motivational intervention versus assessment only.
- The studies were so different that we could not combine their results to answer our question.
- It remains uncertain whether talking therapies affect drinking in people who have problems with other drugs because of the
low quality of the evidence.
- It remains uncertain whether talking therapies for drinking affect illicit drug use in people who have problems with other
drugs. There was not enough information to compare different types of talking therapies.
- Many of the studies did not account for possible sources of bias.
- More high-quality studies, such as randomised controlled trials, are needed to answer our question.
Background 
Description of the condition
Problem alcohol use is common among illicit drug users and is associated with adverse health outcomes, which include
physical, psychological and social implications (Srivastava 2008). NIDA (National Institute on Drug Abuse) meta-analyses of
US clinical trials found alcohol use disorders (AUDs) in 38% and 45% of opiate- and stimulants-using treatment seekers,
respectively (Hartzler 2010; Hartzler 2011). An earlier review of literature on the prevalence of 'heavy drinking' among drug
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users enrolled in a methadone maintenance treatment (MMT) found prevalence rates of 13% to 25% (Ottomanelli 1999),
while more recent cross-sectional studies report prevalence from one-third up to 50% in this setting (Maremmani 2007;
McCusker 2001).
Problem alcohol use is an expression that represents a spectrum of distinct drinking patterns (i.e. hazardous, harmful and
dependent drinking). Hazardous drinking 'is likely to result in harm should present habits persist', while harmful drinking,
which is an International Classification of Diseases - Tenth Revision (ICD-10) diagnosis (WHO 1993), 'causes harm to the
health (physical or mental) of the individual' without the presence of dependence (Babor 2001). The term 'dependent
drinkers' refers to individuals who meet criteria for the alcohol dependence syndrome under Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV) or ICD-10 criteria (DSM-IV; WHO 1993).
Problem drug users are at high risk of liver disease resulting from hepatitis C virus (HCV) infection because of its high
prevalence in this population (Smyth 1998). Problem alcohol use is an important factor in determining poor prognosis among
people with HCV as it impacts on progression to hepatic cirrhosis, increased HCV-ribonucleic acid (RNA) levels or fatal
opiate overdose in opiate users (Ostapowicz 1998; White 1999). Teplin 2007 noted that drug users have higher rates of
mood, anxiety and personality disorders, all of which are exacerbated by alcohol use. In addition, there exists some evidence
that alcohol may have a negative impact on outcomes of addiction treatment (Gossop 2000).
The emerging understanding of a high prevalence of problem alcohol use among current or former drug users, allied to the
clear health implications of this problem for this population, necessitates a public health response to this issue.
Description of the intervention
Psychosocial interventions are best described as 'psychologically-based interventions aimed at reducing consumption
behaviour or alcohol-related problems' (Kaner 2007), which exclude any pharmacological treatments. This term refers to a
heterogeneous collection of interventions, which vary depending on their: (a) theoretical underpinnings (e.g. psychodynamic,
behavioural, motivational), (b) duration or intensity (e.g. brief, extended), (c) setting (e.g. primary care based, inpatient), (d)
mode of delivery (e.g. group, individual, web based) or (e) treatment goals (e.g. abstinence oriented, harm reduction). To
date, many psychosocial interventions specifically designed to address problem alcohol use have been described. The most
frequently used interventions include: motivational interviewing (MI), cognitive-behavioural therapy (CBT), psychodynamic
approaches, screening and brief interventions (SBI), family therapy, drug counselling, 12-step programmes, therapeutic
communities (TC) and vocational rehabilitation (VR).
MI is a client-centred approach, but as opposed to its non-directive Rogerian origins, it is a directive therapy system. A
central role is played by the client's motivation and readiness to change. Change within this approach is facilitated over a
series of stages (Prochaska 1992). Relapse is not viewed as a failure to maintain healthy behaviour, but rather as a part
of the process of change (Miller 2004).
CBT draws upon the principles of learning theory. Change in addictive behaviour is approached through altering irrational
assumptions, coping skills training or other behavioural exercises. This therapy often deals with the identification and
prevention of triggers contributing to the drug use. Among the modern approaches utilising such behavioural techniques
are relapse prevention (Marlatt 1996), contingency management (Budney 2001) or community reinforcement approach,
which combines both contingency management and positive reinforcement for non-drinking behaviours (Hunt 1973).
Psychodynamic approaches are based on the assumptions of psychoanalytic theory, which focuses on addressing the
inner conflicts, childhood traumas or problematic relationship themes. They include a range of different methods designed
to deal with the underlying conflicts (e.g. interpersonal therapy, supportive-expressive techniques, etc.) (Crits-Christoph
1999).
SBI are time limited and therefore suitable for non-specialist facilities. Usually, the length and intensity of the intervention
is determined by the levels of risky alcohol consumption (i.e. screening results). It can range from a couple of minutes to
several sessions (three to six) of intervention. Each session includes provision of information and advice (Babor 2001).
Increasingly, brief interventions (BIs) are based on the principles and techniques of MI, so that the distinction between
these two modalities is blurred in this regard.
Family therapy: the therapeutic change is achieved via intervening in the interaction between family members. Families
are directly involved in a therapy session. The family therapist must be competent in eliciting the strengths and support of
the wider family system. Frequently used family therapy models include multisystemic therapy, network therapy solution-
focused brief therapy, etc. (CSAT 2004).
Drug counselling: addiction is viewed as a chronic illness that has serious consequences to the health of the individual
and social functioning, in consonance with the 12-step model. Recovery includes spiritual components and attendance at
fellowship meetings as well. Primary focus of this approach is to help the patient attain abstinence by promoting
behavioural changes including trigger avoidance, sport and other constructive activities. Both individual and group forms
of drug counselling have been used in the largest collaborative cocaine treatment study (Crits-Christoph 1999).
12-step model: emphasises powerlessness of an individual over the addiction, which is seen as a disease, and a need for
a spiritual recovery. The foundations of this approach lie in the 12 steps and an accompanying document - 12 traditions (
Alcoholics Anonymous 1939). The largest of all 12-step programmes is Alcoholics Anonymous (AA) and all other
programmes evolved from it (e.g. Narcotics Anonymous, Al-Anon etc.). AA meetings, besides the 12 steps, utilise well-
established therapeutic factors of group psychotherapy, such as group cohesiveness, interpersonal learning (i.e.
sponsorship), peer pressure, etc.
TC is a long-term (18 to 24 months), drug-free model of treatment, which usually runs in a residential form. This approach
relies on community itself, as the main therapeutic factor, and also other factors, such as peer feedback, role-modelling or
recapitulation of the primary family experience. Community has a high degree of autonomy, is democratic and each
member has a clearly defined role and responsibilities within the structure of TC. A structured regimen of daily activities in
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the TC often includes formal individual or group therapy sessions along with other educational and work activities (De
Leon 2000).
VR employment is seen as an important element of a successful rehabilitation from drug addiction and is often considered
as one of its key indicators (Platt 1995). VR aims to increase the employability of drug users by developing their job
interview skills or obtaining further qualifications. A necessary part of increasing ex-users' access to the job market is
linking with potential employers and addressing their concerns and prejudices related to drug users. An example of VR for
unemployed MMT patients is the customised employment supports model (Blankertz 2004).
How the intervention might work
Substantial evidence has described the value of psychosocial interventions in treating problem alcohol use.
A review by Raistrick 2006 presented data on the effectiveness of many such interventions, including screening, further
assessment, BIs, more intensive treatments that can still be considered 'brief' and alcohol-focused specialist treatments.
They reported mixed evidence on longer-term effects of BIs and whether extended BIs add anything to the effects of simple
BI.
The Mesa Grande project, which reviewed 361 controlled clinical trials (CCTs) (a three-year update), found BIs to be the
most strongly supported psychosocial treatment effective in treating AUDs (Miller 2002). These findings are supported by an
Australian systematic review that found BIs to be effective in reducing alcohol consumption for drinkers without dependence
or those with a low level of dependence (Shand 2003). Another meta-analysis found positive effect of BIs to be evident at the
follow-up points of three, six and 12 months, and these results were more apparent when dependent drinkers were excluded
(Moyer 2002). Indeed, dependent drinkers have been excluded from much of the research indicating that they are possibly
unsuitable for BI and should be routinely referred to specialist treatment (Raistrick 2006).
While BIs are generally delivered across a range of settings, primary care has an important role in delivery of BIs for problem
alcohol use among problem drug users. BIs are well suited to primary care owing to their feasibility, they can be delivered in
general settings by non-specialist staff in a short period of time, and they can also be delivered to patients not actively
seeking treatment (Kaner 2007; Raistrick 2006).
The benefits of primary care-based interventions for people with problem alcohol use have been demonstrated by a
Cochrane review (Kaner 2007), although the authors have reported considerable variation in trials and the effect of BIs
appeared equivocal among women. Another systematic review of brief, multi-contact behavioural counselling among adult
patients attending primary care found a reduction of 13% to 34% in average of drinks per week (Whitlock 2004).
In conclusion, brief psychosocial interventions are feasible and potentially highly effective components of an overall public
health approach to reducing problem alcohol use, although considerable variation in effectiveness trials exists and problem
drug users from primary care settings are under-represented in these trials (Kaner 2007; Whitlock 2004).
Because BIs have been developed and evaluated mainly in conventional general practice settings, it is not clear whether
they can be effectively applied to excessive drinking among illicit drug users, or whether new forms of intervention need to be
developed and evaluated. Could the 'advice-giving' form of BI be effective in illicit drug users or are motivational techniques,
in which the impetus for change comes from the user, more likely to be effective in this population?
Why it is important to do this review
The described evidence of a high prevalence and serious consequences of problem alcohol use among illicit drug users
highlights an opportunity for a Cochrane systematic review in this population. The question being asked in this review is
important also because there are no other systematic reviews published that could help answer it.
Two narrative literature reviews have dealt with this question to date. The older of these reviews discussed six reports of four
studies among methadone patients and saw some promise in the contingency management procedures (Bickel 1987). A
more recent review described implications of combining behavioural and pharmacological treatments, that are effective in
treating either alcohol- or drug-use disorders alone, for the treatment of people who have both of these disorders (Arias 2008
). While pointing to the paucity of research specifically focused on the treatment of people with co-occurring alcohol and other
substance use disorders, the reviews concluded that successful treatment must take into account both alcohol- and drug-use
disorders. Additionally, one narrative review on treating people seeking therapy primarily for alcohol problems, who also use
other drugs, concurred in this idea (Miller 1996).
Cochrane reviews have so far examined the effectiveness of psychosocial interventions for stimulant, opiate and alcohol use
disorders (Amato 2011; Amato 2011b; Knapp 2007; Lui 2008; Mayet 2004; Minozzi 2011). Although other reviews and
review protocols targeted poly-drug use, they concentrated either on specific populations, for example women and
adolescents, or particular interventions, such as case management and MI, but not on 'alcohol-specific' interventions (Dalsbø
2010; Hesse 2007; Smedslund 2011; Smith 2006; Terplan 2007; Thomas 2008). None of the published reviews on
psychosocial interventions examined the effectiveness of alcohol-specific interventions in problem drug users. The main
problem driving the lack of good studies in this area seems to flow from the administrative separation of drug from alcohol
problems. This separation has led researchers to focus on one or the other but not on both. In the US, the National Institutes
of Health (NIH) plan to correct this separation by forming a new institute that covers both drugs and alcohol – the proposed
National Institute of Substance Use and Addiction Disorders (NIH 2012).
The lack of systematic evaluation, together with the anticipated differences in the responsiveness of problem drug users to
psychosocial interventions, provides additional reasons for conducting this review. In another words, results of reviews on the
effectiveness of this type of intervention among the general population might not be applicable to specific patient groups,
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such as drug users, because they may have different responsiveness to psychosocial interventions (Nilsen 2010).
Several factors could possibly influence the responsiveness of drug users to treatment interventions, for example stability of
drug use, engagement with the service, concurrent personality disorders, etc. For example, evidence suggests that drug
users with antisocial personality disorder are more likely to respond to rewarding than to punitive approaches (Messina 2003
), and the use of more intensive psychosocial interventions is recommended in those who achieved sufficient degree of
stability and compliance with service regimen (Pilling 2010).
Objectives 
To determine the effectiveness of psychosocial interventions targeting problem alcohol use versus other treatments in illicit
drug users. Especially the effectiveness on reducing alcohol consumption.
Methods 
Criteria for considering studies for this review 
Types of studies 
Randomised controlled trials (RCTs) and CCTs.
Types of participants 
Adult (≥ 18 years) problem drug users attending a range of services (i.e. community, inpatient or residential (including opiate
substitution treatment)). Problem drug use was defined by European Monitoring Centre for Drugs and Drug Addiction, as
'injecting drug use or long-duration/regular use of opioids, cocaine and/or amphetamines' (EMCDDA 2008, p. 10). This
definition included other similar terms too, for example substance use, misuse, abuse, dependence or addiction.
Only studies that defined participants as problem drug and alcohol users at randomisation were included. Studies with
problem drug users without concurrent problem alcohol use were excluded. People whose primary drug of use was alcohol
were excluded from this review.
Types of interventions 
Experimental interventions: any psychosocial intervention that is described by the study's author as such, compared to:
Control interventions: other psychosocial interventions that will allow for comparisons between different types of interventions
(e.g. CBT, contingency management, family therapy, etc.), standard care, no intervention, waiting list, placebo/or any other
non-pharmacological therapy (including moderate drinking, assessment only).
We intended to exclude studies comparing psychosocial with pharmacological treatments. However, trials with two
psychosocial arms and pharmacological arms were exempted from this rule.
Types of outcome measures 
Primary outcomes
 Alcohol use (reduction or stabilisation) as measured by either biological markers or self-report tests.1.
Secondary outcomes
Illicit drug use (changes in illicit drug use) as measured by either biological markers or self-report tests.1.
Engagement in further treatment (i.e. drop-out rates, utilisation of health services).2.
Alcohol-related problems or harms as represented by physical or mental health outcomes associated with problem alcohol3.
use. We planned to pool the results from individual trials if sufficient number of studies used a measure of alcohol
problems and the included studies utilised similar instruments to measure their outcomes. However, this was not possible
and the secondary outcomes are described for individual trials only.
We intended to examine the sustained benefit of the intervention at three, six and 12 months through the subgroup analyses.
However, insufficient information precluded this type of analysis.
Search methods for identification of studies 
Electronic searches 
We searched the following electronic databases (search date: 22 Nov 2011):
MEDLINE (PubMed) (1966 to Nov 2011);1.
CINAHL (EBSCO Host) (1982 to Nov 2011);2.
the Cochrane Central Register of Controlled Trials (CENTRAL)(The Cochrane Library, Issue 11, Nov 2011);3.
PsycINFO (ProQuest) (1872 to Nov 2011);4.
EMBASE (Elsevier, EMBASE.com) (1974 to Nov 2011);5.
Cochrane Drugs and Alcohol Group (CDAG) Specialized register* (1956 to Nov 2011; 230 hits).6.
* All trials from the CDAG Specialized Register can be found in The Cochrane Library by doing a search on SR-ADDICTN.
Databases were searched using a strategy developed incorporating the filter for the identification of RCTs (Higgins 2011),
combined with selected MeSH terms and free-text terms relating to alcohol use. Electronic searches were conducted by the
CDAG Group's Trials Search Co-ordinator (databases 1-3, 5-6) and the first author of the review (4). The MEDLINE search
strategy was translated into the other databases using the appropriate controlled vocabulary as applicable. Since the initial
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search yielded several RCTs, we continued to search the databases with the RCT filter. Results of the electronic searches
were collated into a single EndNote database.
The search strategies for all databases are shown in Appendix 1, Appendix 2, Appendix 3, Appendix 4 and Appendix 5.
In addition, we searched for ongoing clinical trials and unpublished studies via Internet searches on the following sites:
www.controlled-trials.com (search date: 5 Apr 2012)1.
www.clinicaltrials.gov (search date: 30 Mar 2012)2.
www.centrewatch.com (search date: 29 Mar 2012)3.
www.who.int/ictrp/en/, International Clinical Trials Registry Platform (search date: 29 Mar 2012)4.
Searching other resources 
We searched also:
reference lists of articles considered eligible based on full report screening and other relevant papers;1.
conference proceedings (online archives only) of the Society for the Study of Addiction, International Harm Reduction2.
Association, International Conference on Alcohol Harm Reduction and American Association for the Treatment of Opioid
Dependence;
contacted investigators and relevant trial authors seeking information about unpublished or incomplete trials.3.
All searches included non-English language literature and studies with English abstracts were assessed for inclusion. When
considered likely to meet inclusion criteria, abstracts were translated.
Data collection and analysis 
Selection of studies 
Two review authors (JK, CAF) independently screened titles and abstracts and selected studies potentially relevant to the
review. Differences between selection lists were resolved by discussion with a third and fourth review author with respective
thematic and methodological expertise (WC, COG).
Full-text copies of each potentially relevant paper were obtained, as well as full reports of references with inadequate
information in order to definitively determine relevance.
Two review authors (JK, CAF) independently re-evaluated whether studies were eligible for the review or not, according to
the inclusion criteria. A second opinion on several studies was sought from the third author (COG) or an independent expert
(S Minozzi, M Trivela). One review author (JS) inspected citations rejected during the screening on title and abstract and
screening on full report. The processes of abstract screening, study selection and data extraction were facilitated with the
Eppi Reviewer 4 software.
Data extraction and management 
Two review authors (JK, CAF) independently extracted data from the full-text reports using electronic version of an amended
data extraction form of the Cochrane Drug and Alcohol review group (CDAG). Disagreements were resolved by mutual
discussion. A third review author (JS) inspected the extracted outcomes after the two review authors had independently
completed data extraction.
Assessment of risk of bias in included studies
The 'Risk of bias' assessments for RCTs and CCTs in this review were performed using the criteria recommended by the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). The recommended approach for assessing risk
of bias in studies included in Cochrane review is a two-part tool addressing five specific domains (namely, sequence
generation, allocation concealment, blinding, incomplete outcome data and other issues). The first part of the tool involves
describing what was reported to have happened in the study. The second part of the tool involves assigning a judgement
relating to the risk of bias for that entry in terms of high, low or unclear risk of bias. To make these judgements we used the
criteria indicated by the Cochrane Handbook for Systematic Reviews of Interventions adapted to the addiction field. See
table in Appendix 6 for details.
The domains of sequence generation and allocation concealment (avoidance of selection bias) were addressed in the tool by
a single entry for each study.
Blinding of participants and providers was not possible for the kind of intervention. Blinding of outcome assessor (avoidance
of detection bias) was considered separately for objective outcomes (e.g. drop-out, substance use measured by urine
analysis, subjects relapsed at the end of follow-up, subjects engaged in further treatments) and subjective outcomes (e.g.
duration and severity of signs and symptoms of withdrawal, patient self-reported use of substance, side effects, social
functioning as integration at school or at work, family relationship, etc.).
Incomplete outcome data (avoidance of attrition bias) was considered for all outcomes except for the drop-out from the
treatment, which is very often the primary outcome measure in trials on addiction. It was assessed separately for results at
the end of the study period, and for results at follow-up.
Measures of treatment effect
The results were not pooled in a meta-analysis owing to a substantial clinical and statistical heterogeneity. For continuous
data, mean differences (MD) between the intervention and comparator groups with 95% confidence intervals (CI) were
calculated. Dichotomous outcomes were presented as risk ratios (RR), with 95% CIs.
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Unit of analysis issues 
The meta-analysis was not performed, therefore unit-of-analysis error was not an issue. Only one multi-arm trial was
included in the review and it was not used more than once in any of the comparisons.
Dealing with missing data
Four authors of original studies were contacted by email for missing data (April 2012) and reminded after two weeks. To
date, two study authors have responded and provided additional information.
Assessment of heterogeneity 
Investigations of heterogeneity were not conducted owing to the low number of included studies.
Assessment of reporting biases
The potential for reporting bias was planned to be further explored by funnel plots if more than 10 RCTs were included;
however, this was not possible because only four RCTs were found.
Data synthesis
A formal meta-analysis was not possible owing to substantial differences between studies; there were no two studies similar
enough to be considered for pooling. Results of included studies are reported individually for each trial, re-expressed as RRs
for dichotomous outcomes and MDs for continuous outcomes, and reported with 95% CIs. A fixed-effect model was used
because there was only one study for each comparison.
Subgroup analysis and investigation of heterogeneity 
Investigations of heterogeneity were not conducted. If sufficient information had been available, the following subgroup
analyses were planned:
types of psychosocial interventions (e.g. motivational vs. behavioural or BIs);1.
length of the interventions (short, medium, extended).2.
The following subgroup analyses were also anticipated, but not performed:
sustained benefit at six and 12 months after intervention;1.
gender differences;2.
single-drug (alcohol) versus poly-drug focused interventions;3.
single-drug (alcohol) versus poly-drug focused interventions, which also address other health-related behaviours.4.
Sensitivity analysis
If sufficient information had been available, sensitivity analyses were planned according to the methodological quality criteria
used for study inclusion:
studies with a high risk of bias were to be excluded from the analysis; this decision was to be based on a pre-defined cut-
off score (i.e. studies judged to be at high risk of bias for three and more risk items, including selection bias, were to be
excluded);
a separate sensitivity analysis was to be performed excluding CCTs.
Consumer participation
Consumer participation in the preparation of the protocol and the review itself was sought by: a) the first review author (JK),
who is a member of the Cochrane Consumers Network, b) the Consumers network was approached to assist with a plain
language summary of the review, and c) one of the co-authors of this review (EK) contributed to consumer consultation
during the protocol and review development, as he was a practicing clinician in a healthcare facility with a high prevalence of
this problem.
Results 
Description of studies 
See Characteristics of included studies and Characteristics of excluded studies tables.
Results of the search
Electronic searches yielded 7207 abstracts for review, and six additional records were identified through searching other
sources. Duplicates were removed (by S. Mitrova) and 5523 references were excluded on the basis of title and abstract; 25
reports were acquired in full text for more detailed evaluation; 18 full-text reports were excluded and seven reports were
included (describing four RCTs). No additional studies were found through reference checking. The process and results of
study identification are outlined in a flow diagram (Figure 1) according to the PRISMA statement (Moher 2009).
Included studies
Four studies (594 participants) were eligible for this review. The studies assessed the effectiveness of six psychosocial
interventions: CBT, 12-step facilitation (TSF), BI, hepatitis health promotion (HHP), MI and brief motivational intervention
(BMI).
Type of psychosocial intervention and setting
CBT versus TSF in an outpatient clinic (Carroll 1998).1.
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BI versus treatment as usual in an outpatient clinic with/out opioid substitution treatment (Feldman 2011).2.
MI (group) versus HHP in an opioid substitution clinic (Nyamathi 2010).3.
MI (single) versus HHP in an opioid substitution clinic (Nyamathi 2010).4.
BMI versus assessment only in a needle exchange programme (Stein 2002a).5.
Countries in which the studies were conducted: three studies were conducted in USA and one in Switzerland
Duration of the trials: range from four to 12 weeks (plus various follow-ups), mean 7.5 weeks. Between one and 16 sessions
were offered to participants, mean 5.5 (from 15 minutes to 16 hours of treatment time).
Participants: 594 problem drug users*: 33% were female. Mean age was 38.3 years.
*one multi-arm trial included 122 participants (Carroll 1998); however, only two psychosocial arms (N = 41) were considered
for this review.
See Characteristics of included studies table for more detailed information.
Excluded studies
Thirty studies did not meet the criteria for inclusion in this review, for more information see Characteristics of excluded
studies table.
The grounds for exclusion were: type of intervention not in the inclusion criteria (no studies); type of participants not in the
inclusion criteria (23  studies); type of outcomes not in the inclusion criteria (six studies); study design not in the inclusion
criteria (one  study).
Risk of bias in included studies 
Summary results across studies for each domain, see Figure 2 and Figure 3. See Characteristics of included studies table
for more detailed information.
Allocation (selection bias)
Random sequence generation
Random sequence generation was judged as adequate in two studies (for one of them this was based on unpublished
information from email communication with the study authors), and unclear in the remaining trials.
Allocation concealment
Only one study was judged being at low risk of bias, one was judged at high risk of bias and the remaining at unclear risk of
bias.
Blinding (performance bias and detection bias)
Objective outcomes
abstinence or use of substance measured by patients with negative urine-tests, or breathalysers: participants and
personnel were not blinded in all studies for the kind of interventions, and objective outcomes were not reported in the
trials. They were used as an additional measure to confirm abstinence in two studies.
Subjective outcomes
abstinence or use of substance as measured by self-reported or interviewer-administered questionnaires: participants and
personnel were not blinded in all studies for the kind of interventions; two studies (50%) specified that outcome assessors
were blinded and were judged to be at low risk of bias. Two studies reported that the outcome assessor was not blinded
and were judged at high risk of bias; for one of them this is unpublished information from email communication with the
study authors.
Incomplete outcome data (attrition bias)
End of study outcomes
(except retention in treatment): only one study measured this type of outcome and it was judged as high risk because the
drop-out rates were not balanced across all groups in the trial (e.g. "the psychotherapy groups had significantly lower
retention rates than the medication groups" (Carroll 1998).
Follow-up outcomes
(except retention in treatment): three studies were judged to be at low risk of bias because there were few patients (less
than 10%) withdrawn from the studies, or there was a high rate of drop-out but percentages were balanced across
intervention groups and reasons for withdrawn were provided, or authors performed an intention to treat (ITT) analysis.
One study was judged to be at high risk of bias because of a high drop-out rate, which was unbalanced across groups.
Effects of interventions 
Meta-analysis of all included studies was not possible. The results were summarised according to the type of psychosocial
intervention, with comparisons of quantitative data where possible. The included studies used different questionnaires to
measure their outcomes and for many of them the authors did not report the post-treatment/follow-up scores or they did not
state what was considered to represent mild, moderate and severe categories. This prevented comparison of results across
studies. One study had three arms, in this case they were entered into two separate comparisons (group and single format),
so they were not counted twice. See Characteristics of included studies table for more detailed information.
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We present the effects of the interventions by comparisons examined in the primary studies. Primary outcome was alcohol
use or abstinence and secondary outcome was illicit drug use or abstinence. Other secondary outcomes were planned at the
protocol stage of the review: engagement in further treatment (i.e. drop-out rates, utilisation of health services) and alcohol-
related problems or harms. These are not reported here because they were not measured in the identified trials.
1. Cognitive-behavioural coping skills training versus 12-step facilitation
Continuous outcomes
1.1.1 Alcohol abstinence as maximum number of weeks of consecutive alcohol abstinence during treatment
One study, 41 participants (Carroll 1998), MD 0.40 (95% CI -1.14 to 1.94), the difference was not statistically significant, see
Analysis 1.1.
1.1.2 Illicit drug abstinence as maximum number of weeks of consecutive abstinence from cocaine during treatment
One study, 41 participants (Carroll 1998), MD 0.80 (95% CI -0.70 to 2.30), the difference was not statistically significant, see
Analysis 1.1.
1.2.1 Alcohol abstinence as number achieving three or more weeks of consecutive alcohol abstinence during treatment
One study, 41 participants (Carroll 1998), RR 1.96 (95% CI 0.43 to 8.94), the difference was not statistically significant, see
Analysis 1.2.
1.2.2 Illicit drug abstinence as number achieving three or more weeks of consecutive abstinence from cocaine during
treatment
One study, 41 participants (Carroll 1998), RR 1.10 (95% CI 0.42 to 2.88), the difference was not statistically significant, see
Analysis 1.2.
1.2.3 Alcohol abstinence during follow-up year
One study, 41 participants (Carroll 1998), RR 2.38 (95% CI 0.10 to 55.06), the difference was not statistically significant, see
Analysis 1.2.
1.2.4 Illicit drug abstinence as abstinence from cocaine during follow-up year
One study, 41 participants (Carroll 1998), RR 0.39 (95% CI 0.04 to 3.98), the difference was not statistically significant, see
Analysis 1.2.
2. Brief intervention versus treatment as usual
Continuous outcomes
2.1.1 Alcohol use as AUDIT scores at three months
One study, 110 participants (Feldman 2011), MD 0.10 (95% -2.96 to 3.16), the difference was not statistically significant, see
Analysis 2.1.
2.1.2 Alcohol use as AUDIT Scores at nine months
One study, 110 participants (Feldman 2011), MD 1.50 (95% CI -1.74 to 4.74), the difference was not statistically significant,
see Analysis 2.1.
2.1.3 Alcohol use as number of drinks per week at three months
One study, 110 participants (Feldman 2011), MD 2.40 (95% CI -4.59 to 9.39), the difference was not statistically significant,
see Analysis 2.1.
2.1.4 Alcohol use as number of drinks per week at nine months
One study, 110 participants (Feldman 2011), MD -1.70 (95% CI -8.93 to 5.53), the difference was not statistically significant,
see Analysis 2.1.
Dichotomous outcomes
2.2.1 Alcohol use as decreased alcohol use at three months
One study, 110 participants (Feldman 2011), RR 0.32 (95% CI 0.19 to 0.54), the difference was statistically significant (P <
0.0001) in favour of treatment as usual, see Analysis 2.2.
2.2.2 Alcohol use as decreased alcohol use at nine months
One study, 110 participants (Feldman 2011), RR 0.16 (95% CI 0.08 to 0.33), the difference was statistically significant (P <
0.0001) in favour of treatment as usual, see Analysis 2.2.
3. Motivational interviewing (group) versus hepatitis health promotion
Continuous outcomes
3.1.1 Alcohol use (unpublished) as number of standard drinks consumed per day over the last 30 days
One study, 147 participants (Nyamathi 2010), MD -0.40 (95% CI -2.03 to 1.23), the difference was not statistically significant,
see Analysis 3.1.
3.1.2 Illicit drug use (unpublished) as frequency of drug use (as measured by Addiction Severity Index - ASI drug)
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One study, 147 participants (Nyamathi 2010), MD 0.00 (95% CI -0.03 to 0.03), the difference was not statistically significant,
see Analysis 3.1.
3.1.3 Illicit drug use (unpublished) as a composite drug score (frequency*severity for all drugs taken)
One study, 151 participants (Nyamathi 2010), MD 0.00 (95% CI -0.42 to 0.42), the difference was not statistically significant,
see Analysis 3.1.
This study reported an additional outcome as a change score for: daily drug use since baseline (past 30 days and six-month
recall). We do not report this calculated variable here because authors provided us with unpublished results of two original
variables that fed into this aggregate variable. Moreover, the published article reported scores for this variable as a mean
change between assessment scores together with standard errors (SEs), which would have to be transformed into standard
deviations (SDs).
Dichotomous outcomes
3.2.1 Alcohol use as greater than 50% reduction in number of standard drinks consumed per day over the last 30 days
One study, 166 participants (Nyamathi 2010), RR 1.10 (95% CI 0.82 to 1.48), the difference was not statistically significant,
see Analysis 3.2.
3.2.2 Alcohol abstinence as abstinence from alcohol over the last 30 days
One study, 166 participants (Nyamathi 2010), RR 0.88 (95% CI 0.49 to 1.58), the difference was not statistically significant,
see Analysis 3.2.
4. Motivational interviewing (single) versus hepatitis health promotion
Continuous outcomes
4.1.1 Alcohol use (unpublished) as number of standard drinks consumed per day over the last 30 days
One study, 155 participants (Nyamathi 2010), MD -0.10 (95% CI -1.89 to 1.69), the difference was not statistically significant,
see Analysis 4.1.
4.1.2 Illicit drug use (unpublished) as frequency of drug use (as measured by Addiction Severity Index - ASI drug)
One study, 155 participants (Nyamathi 2010), MD 0.00 (95% CI -0.03 to 0.03), the difference was not statistically significant,
see Analysis 4.1.
4.1.3 Illicit drug use (unpublished) as a composite drug score (frequency*severity for all drugs taken)
One study, 157 participants (Nyamathi 2010), MD -0.10 (95% CI -0.46 to 0.26), the difference was not statistically significant,
see Analysis 4.1.
This study reported an additional outcome as a change scores for: daily drug use since baseline (past 30 days and six-month
recall). We do not report this calculated variable here because authors provided us with unpublished results of two original
variables which fed into this aggregate variable.
Dichotomous outcomes
4.2.1 Alcohol use as greater than 50% reduction in number of standard drinks consumed per day over the last 30 days
One study, 177 participants (Nyamathi 2010), RR 0.92 (95% CI 0.68 to 1.26), the difference was not statistically significant,
see Analysis 4.1.
4.2.2 Alcohol abstinence as abstinence from alcohol over the last 30 days
One study, 177 participants (Nyamathi 2010), RR 0.97 (95% CI 0.56 to 1.67), the difference was not statistically significant,
see Analysis 4.1.
5. Brief motivational intervention versus assessment only
Continuous outcomes
5.1.1 Alcohol use as number of days in the past 30 days with alcohol use at one month
One study, 187 participants (Stein 2002a), MD -0.30 (95% CI -3.38 to 2.78), the difference was not statistically significant,
see Analysis 5.1.
5.1.2 Alcohol use as number of days in the past 30 days with alcohol use at six months
One study, 187 participants (Stein 2002a), MD -1.50 (95% CI -4.56 to 1.56), the difference was not statistically significant,
see Analysis 5.1.
Dichotomous outcomes
5.2.1 Alcohol use as 25% reduction of drinking days in the past 30 days
One study, 187 participants (Stein 2002a), RR 1.23 (95% CI 0.96 to 1.57), the difference was not statistically significant, see
Analysis 5.2.
5.2.2 Alcohol use as 50% reduction of drinking days in the past 30 days
One study, 187 participants (Stein 2002a), RR 1.27 (95% CI 0.96 to 1.68), the difference was not statistically significant, see
Analysis 5.2.
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5.2.3 Alcohol use as 75% reduction of drinking days in the past 30 days
One study, 187 participants (Stein 2002a), RR 1.21 (95% CI 0.84 to 1.75), the difference was not statistically significant, see
Analysis 5.2.
5.2.4 Alcohol use as one or more drinking days' reduction in the past 30 days
One study, 187 participants (Stein 2002a), RR 1.12 (95% CI 0.91 to 1.38), the difference was not statistically significant, see
Analysis 5.2.
5.2.5 Alcohol use as seven or more drinking days' reduction in the past 30 days
One study, 187 participants (Stein 2002a), RR 1.67 (95% CI 1.08 to 2.60), the difference was statistically significant in favour
of BI (P = 0.02), see Analysis 5.2.
Other analyses
The following subgroup analyses were planned at the protocol stage of this review:
type of psychosocial intervention (e.g. motivational vs. behavioural or BIs);
length of the intervention (short, medium, extended);
sustained benefit at six and 12 months after intervention;
gender differences;
single-drug (alcohol) versus poly-drug focused interventions;
single-drug (alcohol) versus poly-drug focused interventions which also address other health-related behaviours;
studies with low and unclear risk of bias.
None of the planned subgroup analyses were performed because there were not enough data/studies and high/unclear risk
of bias in the included trials. Sensitivity analysis, assessment of heterogeneity and assessment of reporting biases were not
performed for the same reasons.
Discussion 
Summary of main results
Four studies involving 594 participants were included in this review. The studies assessed the effectiveness of six
psychosocial interventions: CBT, TSF, BI, HHP, MI and BMI.
There was significant clinical and reporting heterogeneity among the included studies, which precluded meta-analysis. The
outcomes were analysed only in single studies. Comparing different psychosocial interventions, there was only one study for
each comparison. Most of the comparisons were not statistically significant, except for decreased alcohol use at three
months (RR 0.32; 95% CI 0.19 to 0.54) and nine months (RR 0.16; 95% CI 0.08 to 0.35) in the Feldman 2011 study.
Surprisingly, these results favoured the control intervention. This could be interpreted in the light of the main limitations of this
study, namely, the standard intervention provided to the control group was 'too strong' to enable reasonable comparison with
the intervention group, and the intervention group had a high proportion of people with alcohol addiction who received the 15-
minute-long brief alcohol intervention. This is in contradiction to the manual for BIs, which states that people with alcohol
addiction should not receive BI, but should be referred to a specialised, more intensive treatment (Babor 2001). Evidence
from other systematic reviews examining the general population indicates that BI is effective for harmful/hazardous use, but
not for dependence (Moyer 2002; Raistrick 2006). Finally, participants receiving BMI were significantly more likely to reduce
their alcohol use by seven or more days in the past 30 days at six months' follow-up, compared to control group (RR 1.67;
95% CI 1.08 to 2.60).
Overall completeness and applicability of evidence
The identified studies are not sufficient to address all objectives of this review. All included studies were conducted in US and
Switzerland, which limits their applicability to other contexts. A substantial proportion of participants in the included studies
had significant problems with alcohol (e.g. a diagnosis of abuse or dependence), which may have impacted on the
effectiveness of the short-term therapies offered to them. These people may require more intensive interventions, as BIs
have been shown to be effective among people with less severe alcohol problems (Raistrick 2006). Only one study examined
a longer type of intervention (i.e. 16 sessions); however, it included only 41 participants and reported their outcomes in a way
that precluded comparison with other studies (Carroll 1998).
How do the results of this review fit into the context of current practice? This review selected a very narrow clinical question
that was limited to a very specific population of patients or clients. Although the size of this population is not negligible, it is
highly unlikely that all of the patients of a treatment service in a real-life setting will have both of the conditions selected as
the eligibility criteria for this review. These stringent eligibility criteria strengthened the internal validity of the review; however,
with an inevitable detriment to its external validity. A typical clinician in an actual treatment clinic would normally deal with a
mixture of problem drug users who may or may not have other concurrent conditions or co-morbidities. To manage this
demanding patient workload, they may want to consider other studies, which did not meet the eligibility criteria of our review
(see Characteristics of excluded studies table).
Quality of the evidence
Key methodological limitations
Methodological quality of the included studies was generally considered as low.
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Half of the studies failed to describe random sequence generation and allocation concealment satisfactorily, with one trial
being judged as high risk of allocation concealment. Two studies had low risk of bias on sequence generation. None of the
studies were double blinded owing to the type of intervention assessed (psychosocial). For risk of bias related to incomplete
outcome data, end-of-study outcomes were assessed in one trial only, and this was judged to be at high risk of bias. Three
studies were judged to be at low risk of bias related to incomplete outcome data at follow-up, and one was judged as unclear
risk.
Regarding the risk of bias at an outcome level, we could not assess the objective outcomes (alcohol/drug use measured by
breathalysers or urine-analysis) because they were used only as an additional measure to check for accuracy of the self-
reported alcohol/drug use in two studies, and therefore their scores were not reported in the primary studies. Two studies did
not use objective measures of outcomes at all. For subjective outcomes (alcohol/drug use measured by self-reports), two
studies were judged at unclear or high risk of detection bias. Sensitivity analysis, including or excluding studies at high risk of
bias, was not performed owing to a small number of identified studies. Similarly, it was impossible to pool the data for illicit
drug use outcomes or any other anticipated secondary outcomes (e.g. physical or psychological health).
Indirectness of evidence
Studies providing indirect evidence about our research question, for example trials that included illicit drug users with and
without a concurrent problem alcohol use, were not included in this review. Other sources of indirectness, for example
interventions, outcomes or comparators, were not identified.
Inconsistency of results
We identified only small unexplained heterogeneity or inconsistency in the results. One trial found the control intervention to
be more beneficial than the experimental intervention on a calculated, dichotomised outcome. Most studies did not find
significant, or found only a small, differences in effectiveness between the compared interventions on their primary
outcomes.
Potential biases in the review process
There is a small chance that we missed some trials during the identification of relevant studies. We did not limit our searches
to studies published in English; however, studies in non-English languages may have been missed because they are
commonly less indexed in the selected databases. Unpublished studies may also have been missed. Unpublished studies
are likely to have negative results, which is why they are not published. None of the authors who were contacted for
information about unpublished or ongoing trials provided this information. Owing to a small number of included studies, we
did not conduct the funnel plot for publication bias. The major limitation of the review process was that most trials did not
provide enough published data, or data in a form that could be extracted for meta-analysis. Although all four authors were
emailed, only two responded and provided further data. Furthermore, we could not include a number of potentially relevant
studies, because they involved drug users without problem alcohol use in their samples.
Agreements and disagreements with other studies or reviews
Comparison of our review with other studies or reviews is complicated by the fact that we did not perform any meta-analysis
and therefore do not have any aggregated results to allow this type of comparison. As described in the background section,
two narrative literature reviews dealt with our research question to date (Arias 2008; Bickel 1987). Similarly to our work,
these reviews were unable to identify evidence to answer our question or to conduct a meta-analysis. Subsequently, they
based their conclusions on evidence coming from a mixed type of studies (e.g. case studies, RCTs) or studies that included
illicit drug users without a concurrent problem alcohol use. We excluded this type of studies (see Characteristics of excluded
studies). Furthermore, the review by Arias 2008 discussed 14 reports/studies about treatment of co-occurring alcohol and
cocaine/opioid dependence, two of which were included in our review.
This review is unintentionally tapping into a sensitive controversy regarding the requirement of providing ancillary counselling
services to patients in opioid substitution treatments. The questions are: do additional services provided to patients in MMT
improve their outcomes? Does adding any psychosocial support to standard maintenance treatments yield additional
benefits?
There are a number of ways to answer this question. While previous studies (Amato 2011; Gossop 2006; McLellan 1993;
Schwartz 2012) answered this question by providing evidence of effectiveness of these interventions for general/mixed
conditions/outcomes, which were based on mixed populations with or without concurrent alcohol problems, or based on
mixed types of interventions (i.e. pharmacological plus psychosocial), we focused on a single type of intervention and a 'pure'
population where all participants had both alcohol and drug problems. This may be one of the reasons why our review found
such a small number of studies. Nevertheless, our findings concur with the weakness of the evidence base to answer this
important question, as reported in a previous Cochrane review (Amato 2011).
Another important question is: what constitutes standard maintenance/outpatient treatment? It appears that all standard
treatments contain some type of psychosocial support, which varies considerably, and this makes it difficult to evaluate the
added value of additional services. This was true for studies included in our review and, in addition, the process of
assessment or quick feedback following the assessment, or both, resulted in improved alcohol outcomes among the
participants.
Authors' conclusions 
Implications for practice 
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Based on the weak evidence identified in this review, we cannot recommend using or ceasing psychosocial interventions for
problem alcohol use in illicit drug users. In addition, no reliable conclusions can be made from these data regarding the
effectiveness of different types of psychosocial interventions for the target condition.
Similarly to other conditions, problem alcohol use has better prospects for a successful treatment if approached early.
Evidence from the general population suggests that we need to focus on early detection and intervention as well as try to
influence more established alcohol patterns of use. Early interventions are not implemented into routine care, especially in
the settings where there is a potential for impact owing to high exposure, such as primary health care. Notwithstanding the
clear benefit and feasibility of such early interventions (Kaner 2007), systematic reviews of the literature show that their
integration into primary care is variable (2% to 93%) (e.g. Anderson 2004; Williams 2011), and a similar variation has been
documented in state-level approaches to addressing problem alcohol use in opioid treatment programmes (Harris 2010). In
addition, challenges to successful integration of alcohol-related interventions for problem drug users into general medical
care were reported (Klimas 2012).
Given the high rates of co-occurrence of alcohol and drug problems, integration of alcohol- and drug-
orientated interventions appears as a logical action, but in light of this review remains without an evidence base.
Implications for research 
This review emphasises the need for RCT to test the effectiveness of psychosocial interventions in reducing problem alcohol
use in illicit drug users. We recommend trials of robust methodology, which are reported well to allow for critical appraisal.
For researchers planning an RCT in this area, we recommend to design their study as follows (according to the EPICOT
format for research recommendations on the effects of treatments, see Brown 2006).
E Evidence (what is the current state of the evidence?): the current evidence is limited to four RCTs conducted in
outpatient/community setting, two of them with an accompanying opioid substitution treatment. More RCTs are needed.
P Population (what is the population of interest?): adults, including younger adults, who are identified as problem drug
users with a concurrent and confirmed problem alcohol use; people in or out of a formal addiction treatment.
I Intervention (what are the interventions of interest?): psychosocial intervention, that is talking therapy or counselling (e.g.
MI, CBT, contingency management, family therapy, BI, etc.).
C Comparison (what are the comparisons of interest?): treatment as usual, no intervention, waiting list, other psychosocial
interventions; pharmacological treatments (alone, or in combination with psychosocial treatments); interventions of
different type, length and intensity.
O Outcome (what are the outcomes of interest?): reduction in/abstinence from alcohol or drug use, or from both. In order
to be able to combine outcomes of future trials with our current data, outcome measures of future trials should include
formal validated instruments, for example AUDIT questionnaire. Objective measures of these outcomes should be used in
conjunction to self-reports wherever possible, for example breathalysers, urine-analysis.
T Time stamp (date of literature search): 22 November 2011.
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Differences between protocol and review 
The protocol intended to exclude studies comparing psychosocial with pharmacological treatments. However, trials with two
psychosocial arms and pharmacological arms were exempted from this rule in the review. The subgroup/sensitivity analyses,
anticipated in the protocol, were not conducted owing to a lack of studies. Wording of the primary and secondary outcome
measures from the protocol was simplified for ease of presentation, as follows:
reduction and/or stabilisation of alcohol use = alcohol use or abstinence;1.
illicit drug use outcomes (changes in illicit drug use) = illicit drug use or abstinence.2.
New references have been added to the Background sections: Description of the condition and Why is it important to do this
review, to reflect recent developments in the field. Text in the sections: Experimental interventions and Types of participants
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was reduced to exclude examples. The Newcastle-Ottawa scale for assessing the quality of non-randomised studies (NOS)
was removed from the review as it was not used because observational studies were not included in the review.
Published notes 
Characteristics of studies
Characteristics of included studies 
Carroll 1998
Methods Study design: RCT, single blind
Recruitment modality of participants: individuals seeking treatment at the outpatient
treatment unit of the APT Foundation, or from respondents to newspaper
advertisements or public service announcements
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Participants Number of participants: 122 (41 in 2 arms selected for this review)
Gender: 27% female
Age: mean age 30.8 years (SD 5.5 years)
Condition: "All subjects met current DSM-III-R criteria for cocaine dependence, and for




mean weekly cocaine use 5.4 ± 8.6
days cocaine use/past 30 12.7 ± 8.0
cocaine use g/week/past 30 days 4.6 ± 6.6
mean drinks per drinking day/past 30 days 10.2 ± 5.7
days of alcohol use/past 30 days 12.3 ± 8.0
years of cocaine use - lifetime 7.5 ± 3.9
years of alcohol misuse - lifetime 7.1 ± 6.3
life-time psychiatric disorders: any affective disorder 24%, any anxiety disorder 24%,
anti-social personality disorder 42%, any non-ASP personality disorder 35%
ASI composite scores: medical 0.15 ± 0.26, employment 0.71 ± 0.28, legal 0.09 ±
0.18, family/social 0.21 ± 0.15, psychological 0.26 ± 0.17, alcohol 0.30 ± 0.19,
cocaine 0.58 ± 0.24, other drugs 0.06 ± 0.06
race: white 40%, African-American 56%, Hispanic 0%, other 4%
married/cohabiting 42%
unemployed 76%
education: less than high school 40%
primary route of administration: nasal 20%, smoking 72%, intravenous 8%
previous treatment: alcohol 36%, drugs 72%
CBT arm:
Baseline substance use:
mean weekly cocaine use (mean ± SD) 5.6 ± 6.2
days cocaine use/past 30 days; 15.6 ± 6.5
cocaine use g/week/past 30 days 5.0 ± 5.1
mean drinks per drinking day/past 30 days 10.6 ± 8.0
days of alcohol use/past 30 days 18.5 ± 7.6
years of cocaine use - lifetime 5.8 ± 3.1
years of alcohol misuse - lifetime 7.3 ± 6.4
life-time psychiatric disorders: any affective disorder 33%, any anxiety disorder 6%,
anti-social personality disorder 46%, any non-ASP personality disorder 50%
ASI composite scores: medical 0.19 ± 0.29, employment 0.67 ± 0.32, legal 0.09 ±
0.17, family/social 0.12 ± 0.15, psychological 0.16 ± 0.19, alcohol 0.40 ± 0.20,
cocaine 0.58 ± 0.18, other drugs 0.07 ± 0.05
race: white 32%, African-American 63%, Hispanic 1%, other 0%
married/cohabiting 32%
unemployed 53%
education: less than high school 32%
primary route of administration: nasal 11%, smoking 84%, intravenous 5%
previous treatment: alcohol 32%, drugs 58%
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Interventions Description of the experimental and control interventions:
The trial included 5 treatment arms: CBT plus disulphiram; TSF plus disulphiram; CM
plus disulphiram; CBT plus no medication; TSF plus no medication. We considered
only the latter 2 psychosocial arms. CBT was based on Marlatt's relapse prevention
model and TSF was adapted from that used in Project MATCH and was grounded in
the concept of substance dependence as a spiritual and medical disease
Route of delivery: treatments were manual-guided, 4 doctoral-level psychologists
conducted CBT, 2 masters-level clinicians conducted TSF.
Number of participants allocated to each group: 25 in CBT plus no medication; 19 in
TSF plus no medication
Duration of the intervention: 12 weeks, 16 individual sessions
Duration of follow-up: 12 weekly assessments within-treatment, and at 1, 3, 6, 12
months.
Country of origin, setting: a non-profit substance abuse treatment centre (APT
foundation) affiliated with Yale University in New Haven, Connecticut
 
Outcomes 1.1.1 Alcohol abstinence as maximum number of weeks of consecutive alcohol
abstinence during treatment
1.1.2 Illicit drug abstinence as maximum number of weeks of consecutive abstinence
from cocaine during treatment
1.2.1 Alcohol abstinence as number achieving 3 or more weeks of consecutive alcohol
abstinence during treatment
1.2.2 Illicit drug abstinence as number achieving 3 or more weeks of consecutive
abstinence from cocaine during treatment
1.2.3 Alcohol abstinence during follow-up year
1.2.4 Illicit drug abstinence as abstinence from cocaine during follow-up year
 
Notes All sessions were recorded and checked and rated for the accuracy and fidelity of the
intervention
"Subjects also met weekly with an independent clinical evaluator who collected urine
specimens, assessed cocaine and alcohol use and monitored other clinical symptoms"
"Patients were paid $25 for each follow-up interview, with a $10 increase for each
consecutive interview they attended, to encourage more complete data collection. In
addition, patients were paid a $5 bonus for attending an interview within 28 days of the
target interview date"
Only 39 subjects completed the full 12-week treatment (compliant treatment
completers)
Participants in the pharmacological arms stayed longer in treatment (patients were
not blind to their intervention)
The specific type of self-report questionnaires not reported in the primary paper
(1998), only in the follow-up paper
Results are reported as No. of weeks of continuous abstinence
The follow-up report (2000) does not provide any end-point scores (only results of
the Random effects regression model)
Use of cocaine and alcohol were strongly associated with each other during
treatment, particularly for the subjects assigned to disulphiram
 
Risk of bias table





Not enough information provided; e.g. "Of the 122 randomised subjects,
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Bias Authors'judgement Support for judgement






Objective measures used rather as an accuracy check than an outcome
(urine specimens and Brethalyser tests conducted by a blinded evaluator)
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
Low risk Within-study assessments:
"independent clinical evaluator who collected urine specimens, assessed
cocaine and alcohol use; the evaluator saw patients in an office physically
separated from the therapy offices and instructed patients not to disclose
detail of their therapist of treatment"
Follow-up assessments (2000 paper):
"Patients were assessed at face-to-face follow-up interviews conducted 1,
3, 6 and 12 months after the 12-week termination point by an independent
clinical evaluator who was blind to both psychotherapy and
pharmacotherapy condition"
 
Incomplete outcome data (attrition
bias)
End of Study outcomes
High risk Within-treatment assessments (1998):
"Assignment to disulphiram was associated with significantly better
retention in treatment".
The psychotherapy groups had significantly lower retention rates than the
medication groups:
"subjects assigned to disulphiram treatment were retained significantly
longer than those assigned to no medication (8.4 versus 5.8 weeks. F=
8.7, p< 0.05)".
Retention rates:





"However, such analyses, ..., are confounded by differences among the
treatments in retention"
Only 30% completed treatment, however:
"Subjects who remained in treatment the full 12 weeks/16 sessions (n=39)
did not differ from those who did not start treatment or dropped out (n=83)
in terms of gender, race, employment status, route of administration,
presence of lifetime affective, anxiety or antisocial personality disorder, but
those who met criteria for a nonASP Axis II disorder, were significantly
more likely to complete treatment than these who did not (48.1% versus
23.1%)"
Comments:
1) baseline characteristics provided for the ITT sample (N = 122), but
2) rates of consecutive abstinence provided for the exposed sample (N =
117)
3) it is not known whether missing outcome data were balanced in
numbers across intervention groups, because group breakdowns for drop-
outs are not provided.
4) psychotherapy groups (CBT, TSF) differed significantly at baseline: for
frequency of alcohol use; and medication groups had lower baseline
cocaine use
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Bias Authors'judgement Support for judgement
Incomplete outcome data (attrition
bias)
Follow up
High risk All groups had a comparable number of follow-up data points. However,
number of drop-outs not reported for each group separately.
"It is possible that poorer-functioning subjects who dropped out of
treatment early were under-represented in the follow-up data, inflating
outcomes in all groups".
"Participants who completed more sessions had better outcomes during
follow-up"
Subjects with higher age of onset of drug use had more follow-up data
Subjects with non-ASP Axis II disorders had more follow-up data
No significant differences between those followed up and those not
followed on
Percentage of treatment days abstinent from cocaine, percentage of
treatment days abstinent from alcohol, percentage of cocaine-negative
urine screens, medication compliance during treatment
Number of drop-outs and reasons:
Number randomised: 122 (25 TSF, 19 CBT)
Number initiated: 117 (23 TSF, 18 CBT) - no other reason provided
Number removed from the trial: 8 (1 did not comply with medication, 1
medication side effects. 4 clinical deterioration, 2 administrative discharge)
Number drop-outs: 70 (no group breakdowns - no other reasons)
Number completed treatment: 39







Methods Study design: RCT
Recruitment modality of participants: for 1 year, participation in the study was proposed
systematically to each adult outpatient who was treated for opioid or cocaine
dependence
 
Participants Number of participants: 110
Gender: 72.3% male
Age (mean ± SD): 35 ± 7.8 years
Condition: problem alcohol use based on questions from the AUDIT questionnaire, i.e.
excessive drinking (7 ≤ AUDIT score < 13 for men and 6 ≤ AUDIT score < 13 for
women); and alcohol dependence (score > 13); 43.8% were classified as excessive
drinkers and 56.2% as alcohol dependents
Other relevant information: opiate dependence treatment with methadone substitution
(56.2%) or diacetyl morphine (heroin treatment; 12%); no opioid substitution and
treatment for opiate or cocaine dependence (31.7%)
Most patients with cocaine dependence or with opiate dependence also had tobacco or
cannabis dependence. Most patients had 1 or more concomitant psychiatric disorders
(mood disorder, 35.6%; personality disorder, 34%; anxiety disorders, 14.7%; psychotic
disorders, 9.4%). "Diagnoses were established according to the criteria of the ICD-10)
by a resident and a senior psychiatrist"
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Interventions Description of the experimental and control interventions: the intervention group was BI
and the control group was TAU.
(1) BI: BI was delivered in 1 session, based on WHO guidelines, delivered by a trained
staff (4 hours' training). The intervention group received the same TAU as controls.
The outpatient staff consisted of a psychiatrist, general practitioner, psychologist,
nurse, and social worker
(2) TAU: "The control group received TAU in addition to AUDIT and score feedback.
TAU refers to outpatient pharmacological and psychosocial treatment. Maintenance
treatment with methadone or heroin included medical and psychiatric follow-up,
primary health care, psychosocial interventions, and administration of opiate
treatments in a clinical setting. Psychosocial treatment included medical and
psychiatric follow-up, primary health care, psychosocial interventions, and, if
necessary, administration of pharmacotherapy in a clinical setting"
Number of participants allocated to each group: 60 in BI, 52 in TAU
Duration of the intervention (mean ± SD): 16 ± 4.7 minutes
Duration of follow-up: 3 and 9 months
Country of origin, setting: specialised outpatient clinic in the Division of Substance
Abuse of the University Hospitals of Geneva, Switzerland
 
Outcomes 2.1.1 Alcohol use as AUDIT scores at 3 months
2.1.2 Alcohol use as AUDIT Scores at 9 months
2.1.3 Alcohol use as number of drinks per week at 3 months (number of glasses of
alcohol per week, 1 glass: 10 g of alcohol; wine = 100 mL; beer = 250 mL; spirits = 25
mL)
2.1.4 Alcohol use as number of drinks per week at 9 months
2.2.1 Alcohol use as decreased alcohol use at 3 months
2.2.2 Alcohol use as decreased alcohol use at 9 months
2.2.3 and 2.2.4 Increased or unchanged alcohol use at 3 and 9 months (i.e. reverse of
the above)
 
Notes The patients in both groups were already in treatment for opioid or cocaine
dependence before study inclusion. Patients allocated to BI received this intervention 2
or 3 weeks after AUDIT screening
The WHO manual recommends to refer patients with alcohol dependence to specialist
treatment without providing BI
All screened patients received feedback that explained the meaning of their AUDIT
score
Almost 40% of the sample was lost to follow-up
More participants had success (decreased alcohol use) in control group than
intervention. Strong effect of TAU in the control group
 
Risk of bias table
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Bias Authors'judgement Support for judgement
Random sequence generation
(selection bias)
Low risk Quote: "The randomisation scheme was drawn by a statistician, who used
the Web site [http://www.randomizer.org/]. A random permuted block




Low risk Quote: "The sequence was concealed from all investigators with
numbered opaque sealed envelopes prepared by the statistician and
handed over to the physician in charge of the study"
 
Blinding of outcome assessment
(detection bias)
Objective outcomes
Unclear risk Not available, objective measures not used
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
High risk Not stated
Unpublished information: "There is no blinding assessment"
 
Incomplete outcome data (attrition
bias)
End of Study outcomes
Unclear risk Not available. The study did not assess outcomes at the time of the study
end
 
Incomplete outcome data (attrition
bias)
Follow up
Low risk Modified ITT analysis (multiple imputation, random assumption)
At T0 - 1 person not included in analysis because of data-entry errors,
both in both control and intervention group
Number of drop-outs and reasons:
"Of the BI group, 59.3% completed the last observation and of the control
group, 58.8% completed it"
Intervention (T0 = 51, T3 = 29, T9 = 30)
Control (T0 = 59, T3 = 30, T9 = 35)
No reasons provided for drop-outs, but regression showed no differences:
"Logistic regressions showed that the - Type of drinker- and - Treatment
group - did not explain the missingness of data"
"Hence, these variables displayed no particular pattern, meaning that the
data for excessive drinkers and for alcohol-dependent patients, as well as
for the control group and the intervention group, were equally likely to be
missing"
Comment: dichotomous outcomes: 40% of participants dropped out, but




Methods Study design: RCT open label, 3 arms
Recruitment modality of participants: flyers displayed in 5 methadone treatment sites
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Participants Number of participants: 256
Gender: 59.2% male
Age (mean ± SD): 51.2 ± 8.4 years
Condition: reported moderate-to-heavy alcohol use based on questions from the ASI.
Methadone maintenance treatment was an inclusion criterion (minimum 3 months)
Other relevant information: fair/poor health: 60.4%
Depressive symptoms: 80.8%
Poor emotional well-being: 67.5%
Ethnicity: African-American: 45.1%; white: 18.8, Latino: 26.7, Other: 9.4, Education:
high school graduate 58%
Partnered: 54.3%
Employed: 17.3%
Recent alcohol use at baseline (Mean number standard drinks last 30 days): 0-40:
25.1; 41-89: 24.7; 90-180: 26.7; 180+: 23.5
Marijuana use in past 30 days: 16%
IDU in past 30 days: 40%
Smoke > 1 pack/day: 56.1%
Self-help program in past 30 days: 21.2%
Social support: primarily from drug users 12.6%; primarily non-drug users 48.6%, both:
34.9%
 
Interventions Description of the experimental and control interventions: (1) nurse-led HHP group
sessions; (2) MI delivered in group sessions (MI-group), and (3) MI delivered 1-on-1
sessions (MI-single).
(1) HHP: didactic style, also interactive as the group raised questions. Delivered by a
nurse and hepatitis-trained research assistant. Sessions based on "The
comprehensive health seeking and coping paradigm (CHSCP; Nyamathi, 1989),
originally adapted from Lazarus and Folkman's (1984) stress and coping paradigm and
Schlotfeldt's (1981) health seeking paradigm". Staff trained on the integration of the
CHSCP into their education delivery.
Focus: progression of HCV infection and the culturally-sensitive strategies that infected
individuals can adopt to prevent or reduce accumulated damage to liver functioning.
Strategies included: discussing the dangers of alcohol use on hepatitis (cognitive
factors), discussing ways to avoid alcohol and other drugs, eating a balanced diet,
dangers of reinfection of HCV by IDU, receiving unsafe tattoos and piercing, having
unprotected sexual behaviour, and being consistent in engaging in other health-related
behaviours. Additional health promoting activities: enhancing coping, such as seeking
positive social support, getting
support from religion and building self-esteem when afflicted with a history of drug and
alcohol addiction. The HHP was directed by a detailed protocol.
(2) MI-group: focus: alcohol, risky behaviours, MI spirit; by trained MI specialists, i.e. a
PhD-prepared psychologist conducted primarily the MI-group sessions. Content of the
individual and group sessions was identical, guided by a detailed protocol and biweekly
meetings with the investigator and therapists. The average number of participants was
6 (range 5 to 7)
(3) MI-single: focus: alcohol, risky behaviours, MI spirit; a MSW-prepared researcher
conducted primarily the individual MI sessions
Number of participants allocated to each group: HHP: N = 87; MI group: N = 79; MI
single: N = 90
Duration of the intervention: 3 x 60-minute sessions, spaced 2 weeks apart
Duration of follow-up: 6 months
Country of origin, setting: 5 methadone treatment sites in Los Angeles and Santa
Monica, USA
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Outcomes 3.1.1 Alcohol use (unpublished) as number of standard drinks consumed per day over
the last 30 days
3.1.2 Illicit drug use (unpublished) as frequency of drug use (as measured by ASI drug)
3.1.3 Illicit drug use (unpublished) as a composite drug score (frequency*severity for all
drugs taken)
3.2.1 Alcohol use as > 50% reduction in number of standard drinks consumed per day
over the last 30 days
3.2.2 Alcohol abstinence as abstinence from alcohol over the last 30 days
Outcomes 4.1.1 to 4.2.2 refer to the individual (single) format of MI
 
Notes 6 participants reported no alcohol use at baseline
A total of 86.7% of participants completed all 3 sessions and 91.3% completed the 6-
month follow-up
The sessions were open; i.e. participants who had not completed their 3 sessions with
their original cohort could complete with a later cohort.
The original protocol describes HHP as a control intervention (UCG)
Means (SD) of outcomes measures (ASI, TLFB) are not provided for any of the
outcomes; baseline scores are not provided either
 
Risk of bias table
63 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users: Coch...
23 / 51
Bias Authors'judgement Support for judgement
Random sequence generation
(selection bias)
Low risk Quote: "This study was a randomised controlled trial"
Unpublished information: "As participants were enrolled, they were
systematically assigned to each of the three arms. In terms of





High risk Masking: open label
Source of information: published protocol of the trial
 
Blinding of outcome assessment
(detection bias)
Objective outcomes
Unclear risk Not available, objective measures not used
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
High risk Masking: open label
Source of information: published protocol of the trial
 
Incomplete outcome data (attrition
bias)
End of Study outcomes
Unclear risk Not available. The study did not assess outcomes at the time of the study
end
 




All analyses were ITT; however, it is not stated which method of data
imputation was used for ITT analysis
Missing data balanced across groups
Comparability of all 3 arms assessed at baseline
Number of drop-outs and reasons:
MI-S (90), 86% completed all sessions, 9% lost to follow-up
MI-G (79), 85% completed all sessions, 10% lost to follow-up
HHP (87), 89% completed all sessions, 7% lost to follow-up
Unpublished information: "The 6 reported abstainers were distributed as
follows: 2 in MI-Single, 3 in MI-Group and 1 in HHP.
No one was excluded from the final regression model based on ethnicity.
The statement was erroneously carried over from preliminary modelling.
However, since ethnicity was not important in that modelling, it was not
included in the final model and there was no need to exclude anyone
based on ethnicity
The 6 abstainers were excluded from the logistic regression analysis. "A
missing value for drug-using partners caused an additional case to be
omitted (actually there were 248 cases in the regression model rather than
249. Two subjects had missing values for drug-using partners)"
 
Stein 2002a
Methods Study design: RCT
Recruitment modality of participants: study was advertised at 3 NEP sites using
posters and NEP volunteers offered all clients referral cards. NEP clients called a study
telephone to be screened by a research assistant at a separate research site in
hospital. During the initial study visit, all NEP clients presented their study cards
(received at NEP). Between February 1998 and October 1999
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Participants Number of participants: 187
Gender: 119 male (63.6%)
Age: mean 36.2 years
Condition: problem alcohol use, i.e. AUDIT-positive (> 8) active IDUs. "Current alcohol
abuse or dependence diagnosis was ascertained using the SCID interview. 159
(85.0%) met DSM-IV criteria for current alcohol abuse or dependence (80% for abuse,
70% for dependence)."
Other relevant information:
mean education: 11.5 years
ethnicity: 162 (86.6%) Caucasian
most frequently injected drug: heroin for 141 (75.4%) subjects, cocaine for 15
(8.0%), heroin and cocaine for 31 (16.6%)
120 (64.1%) participants visited the NEP at least once a month
mean AUDIT score at screening was 22.2.
159 (85.0%) met DSM-IV criteria for current alcohol abuse or dependence (80% for
abuse, 70% for dependence)
mean ± SD number of drinking days in the past 30 days prior to baseline
assessment: 12.0 ± 10.3
71.4% of quantities on all drinking days exceeded conventional criteria defining
heavy alcohol consumption (5+ drinks for men and 3+ drinks for women)
mean ± SD drinks per drinking days 7.3 ± 5.8
 
Interventions Description of the experimental and control interventions: (1) brief MI and (2) control
group
(1) MI: focus on alcohol use and HIV risk-taking
Goals: to assess the degree to which the patient engages in hazardous drinking; to
identify relationships between alcohol consumption and alcohol-related negative
consequences including HIV risk behaviour; to identify goals for behaviour change and
any barriers to change
Included a written change plan, designed to reduce the link between alcohol
consumption and hazardous behaviours that may lead to negative consequences of
drinking, including HIV risk behaviour
Interventionist trained by studying the manual and watching MI tapes from Project
MATCH
Standard delivery of the MI protocol
Adherence monitoring by: an MI checklist completed by the therapist after each
session and audiotapes of sessions were randomly reviewed by a supervisor trained
in MI
(2) Control: assessment only, approximately 3 hours
Number of participants allocated to each group: 95 in MI, 92 in control group
Duration of the intervention: 2 therapist sessions, 1 month apart; 1st session: 60
minutes, 2nd session: 30 to 45 minutes
Duration of follow-up: 1 and 6 months
Country of origin, setting: NEP clients, study site: Rhode Island Hospital in Providence,
USA
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Outcomes 5.1.1 Alcohol use as number of days in the past 30 days with alcohol use at 1 month
5.1.2 Alcohol use as number of days in the past 30 days with alcohol use at 6 months
5.2.1 Alcohol use as 25% reduction of drinking days in the past 30 days
5.2.2 Alcohol use as 50% reduction of drinking days in the past 30 days
5.2.3 Alcohol use as 75% reduction of drinking days in the past 30 days
5.2.4 Alcohol use as 1 or more drinking days' reduction in the past 30 days
5.2.5 Alcohol use as 7 or more drinking days' reduction in the past 30 days
Secondary outcome: number of days in the past 30 days with IRRB - defined as
answer to 1 question: have you used needles etc. after someone else? (reported only
for a subset of 109 participants in the 2002b paper)
 
Notes Study retention: 96.8% at 6 months
Control and MI subjects received identical research assessments at baseline, 1 and 6
months
at baseline and 1 month later, both MI and control group received a list of referrals
for substance abuse and medical treatment
patients in the control group spent approximately 3 total hours (assessment time)
with research staff, "the assessment included sections on demographics, drug and
alcohol use, drug and alcohol treatment, health-related quality of life, attitudes and
experiences with alcohol and HIV risk behavior"
the assessment control group also experienced meaningful reduction in alcohol use
6-month follow-up: 11 subjects were interviewed in prison and 6 were interviewed by
telephone
total reimbursement: $90 with $20 given at baseline, $30 at the 1-month interview
and $40 at the final interview
65 (34.8%) participants reported 4 or fewer drinking days at baseline: their
maximum possible decrease in drinking days at follow-up is 4 or less (i.e. floor and
ceiling effects)
change in heroin use was not associated with change in alcohol use
the association between change in IRRB days and change in alcohol use days was
not statistically significant
The paper reporting IRRB outcomes (Stein 2002b) was included in another Cochrane
review (Meader 2010), therefore it was not considered for this review
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Bias Authors'judgement Support for judgement
Random sequence generation
(selection bias)
Unclear riskNot enough information provided: "Following the baseline interview
subjects were assigned to treatment conditions using a randomisation
schedule created with permuted blocks of eight assignments." "After





Unclear riskNot stated how the randomisation schedule was prepared: "This method
ensured that the treatment groups were balanced in number to within four
patients throughout the trial. The data manager prepared the
randomisation schedule before the first patient enrolled"
 
Blinding of outcome assessment
(detection bias)
Objective outcomes
Unclear riskNot available. Objective measures used rather as an accuracy check than
an outcome:
"During the initial study visit, all NEP subjects presented their study cards
(received at NEP), underwent blood alcohol level testing (to ensure
subjects were not inebriated, BAL < 0.04)"
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
Low risk "At each follow-up assessment, research assistants were blinded to the
treatment condition of the subject; the interventionist did not perform
research assessments"
 
Incomplete outcome data (attrition
bias)
End of Study outcomes
Unclear riskNot available. The study did not assess outcomes at the time of the study
end
 
Incomplete outcome data (attrition
bias)
Follow up
Low risk "We conducted an intent-to-treat analysis using a conservative 'worst case
scenario' strategy in which observations with missing follow-up data were
assigned the maximum value of 30 drinking days, a data imputation
approach which tends to minimize observed reductions in mean drinking
days across time
To ensure that our substantive results were not sensitive to missing
observations (there were no condition differences in missing data) we
replicated our analyses using observations with complete data (n = 181),
and using other imputation strategies (e.g. mean substitution, regression
estimation and 'best case scenario'). All imputation strategies resulted in
substantively consistent findings.
To evaluate the adequacy of random assignment, we used t- and x2-tests
to compare treatment groups with respect to background characteristics
and baseline measures of drinking behaviours and alcohol problems"
Number of drop-outs and reasons:
There were no study withdrawals: 93 of 95 in the MI group received both
MI sessions: 2 people missed their second session. 6-month follow-up
data were available for 96.8% (N = 181) of the 187 randomly assigned




ASI: Addiction Severity Index; ASP: antisocial personality disorder; BAL: blood alcohol level; BI: brief intervention; CBT:
cognitive-behavioural coping skills training; CM: clinical management; DSM-III-R: Diagnostic and Statistical Manual of Mental
Disorders, Third Edition - Revised; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; HCV:
hepatitis C virus; HIV: human immunodeficiency virus; HHP: hepatitis health promotion; ICD-10: International Classification
of Diseases - Tenth Revision; IDU: injection drug use; ITT: intention to treat; IRRB: injection-related HIV risk behaviour; MI:
motivational intervention; MSW: master in social work; NEP: needle exchange programme; PhD: doctor of philosophy; RCT:
randomised controlled trial; SD: standard deviation; TAU: treatment as usual; TLFB: timeline follow-back; TSF: 12-step
facilitation; UCG: usual care group; WHO: World Health Organization.
Characteristics of excluded studies 
Abou-Saleh 2008
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Reason for exclusion Participants not in the inclusion criteria: participants had alcohol dependence only
 
Azrin 1994
Reason for exclusion Participants not in the inclusion criteria: participants were not problem drug users and
concurrent problem alcohol use not an inclusion criterion
 
Azrin 1996
Reason for exclusion Participants not in the inclusion criteria: participants were not problem drug users and
concurrent problem alcohol use not an inclusion criterion
 
Baker 2005












Reason for exclusion Study design not in the inclusion criteria: not an RCT
 
Bernstein 2005
Reason for exclusion Outcome not in the inclusion criteria: alcohol use was not measured, because the
intervention focused on drug use and the participants were not reported to have
problem alcohol use at randomisation
 
Black 2011




Reason for exclusion Study design not in the inclusion criteria: not an RCT
 
Brown 2007
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Reason for exclusion Participants not in the inclusion criteria: the MST (multi-component smoking treatment)
condition had a continuous drug and alcohol abstinence rate
 
Chermack 2002
Reason for exclusion Study design not in the inclusion criteria: not an RCT
 
Cohen 1982
Reason for exclusion Participants not in the inclusion criteria: concurrent problem alcohol use not an
inclusion criterion for all subjects randomised into trial. Quote: "Approximately one-third
of all the active alcoholics [n=105] were assigned to each of the three study groups
(1983, p864; 1982, p360)." Comment: it is highly probable that non-alcoholics were
randomised into trial. Operative alcoholics (N = 105) versus all subjects randomised
into trial (N = 127)
 
Daeppen 2010
Reason for exclusion Participants not in the inclusion criteria: concurrent problem drug use not an inclusion
criterion. Only 10% to 11% participants smoked cannabis once per week
 
Darker 2011
Reason for exclusion Study design not in the inclusion criteria: not an RCT
 
Drapkin 2008




Reason for exclusion Study design not in the inclusion criteria: not an RCT. A secondary analysis of 2 RCTs
that did not have concurrent problem alcohol use not an inclusion criterion
 
Forsberg 2011
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Reason for exclusion Participants not in the inclusion criteria: participants were eligible if they had alcohol




Reason for exclusion Study design not in the inclusion criteria: not an RCT
 
Staiger 2009
Reason for exclusion Participants not in the inclusion criteria: concurrent problem alcohol use not an
inclusion criterion. Alcohol was used only by 149 of the 166 participants in the 90 days
prior to initial presentation
 
Van Der, 1995




Reason for exclusion Participants not in the inclusion criteria: concurrent problem alcohol use not an












RCT: randomised controlled trial.
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Footnotes
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Data and analyses 
1 Cognitive-behavioural coping skills training (CBT) versus 12-step facilitation (TSF)
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
1.1 Continuous outcomes 1   Mean Difference(IV, Fixed, 95% CI) Subtotals only
   1.1.1 Alcohol abstinence as
maximum number of weeks of
consecutive alcohol abstinence
during treatment
1 41 Mean Difference(IV, Fixed, 95% CI) 0.40[-1.14, 1.94]
   1.1.2 Illicit drug abstinence as
maximum number of weeks of
consecutive abstinence from cocaine
during treatment
1 41 Mean Difference(IV, Fixed, 95% CI) 0.80[-0.70, 2.30]
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1.2 Dichotomous outcomes 1   Risk Ratio(M-H, Fixed, 95% CI) Subtotals only
   1.2.1 Alcohol abstinence as
number achieving 3 or more weeks
of consecutive alcohol abstinence
during treatment
1 41 Risk Ratio(M-H, Fixed, 95% CI) 1.96[0.43, 8.94]
   1.2.2 Illicit drug abstinence as
number achieving 3 or more weeks
of consecutive abstinence from
cocaine during treatment
1 41 Risk Ratio(M-H, Fixed, 95% CI) 1.10[0.42, 2.88]
   1.2.3 Alcohol abstinence during
follow-up year 1 41 Risk Ratio(M-H, Fixed, 95% CI) 2.38[0.10, 55.06]
   1.2.4 Illicit drug abstinence as
abstinence from cocaine during
follow-up year
1 41 Risk Ratio(M-H, Fixed, 95% CI) 0.39[0.04, 3.98]
2 Brief intervention (BI) versus treatment as usual
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
2.1 Continuous outcomes 1   Mean Difference(IV, Fixed, 95% CI) Subtotals only
   2.1.1 Alcohol use as AUDIT scores
at 3 months 1 110 Mean Difference(IV, Fixed, 95% CI) 0.10[-2.96, 3.16]
   2.1.2 Alcohol use as AUDIT
Scores at 9 months 1 110 Mean Difference(IV, Fixed, 95% CI) 1.50[-1.74, 4.74]
   2.1.3 Alcohol use as number of
drinks per week at 3 months 1 110 Mean Difference(IV, Fixed, 95% CI) 2.40[-4.59, 9.39]
   2.1.4 Alcohol use as number of
drinks per week at 9 months 1 110 Mean Difference(IV, Fixed, 95% CI) -1.70[-8.93, 5.53]
2.2 Dichotomous outcomes 1   Risk Ratio(M-H, Fixed, 95% CI) Subtotals only
   2.2.1 Alcohol use as decreased
alcohol use at 3 months 1 110 Risk Ratio(M-H, Fixed, 95% CI) 0.32[0.19, 0.54]
   2.2.2 Alcohol use as decreased
alcohol use at 9 months 1 110 Risk Ratio(M-H, Fixed, 95% CI) 0.16[0.08, 0.33]
3 Motivational interviewing(group) (MI-G) versus hepatitis health promotion (HHP)
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
3.1 Continuous outcomes 1   Mean Difference(IV, Fixed, 95% CI) Subtotals only
   3.1.1 Alcohol use as number of
standard drinks consumed per day
over the last 30 days 
1 147 Mean Difference(IV, Fixed, 95% CI) -0.40[-2.03, 1.23]
   3.1.2 Illicit drug use as frequency
of drug use (as measured by
Addiction Severity Index - ASI drug)
1 147 Mean Difference(IV, Fixed, 95% CI) 0.00[-0.03, 0.03]
   3.1.3 Illicit drug use as a
composite drug score
(frequency*severity for all drugs
taken)
1 151 Mean Difference(IV, Fixed, 95% CI) 0.00[-0.42, 0.42]
3.2 Dichotomous outcomes 1   Risk Ratio(M-H, Fixed, 95% CI) Subtotals only
   3.2.1 Alcohol use as greater than
50% reduction in number of standard
drinks consumed per day over the
last 30 days
1 166 Risk Ratio(M-H, Fixed, 95% CI) 1.10[0.82, 1.48]
   3.2.2 Alcohol abstinence as
abstinence from alcohol over the last
30 days
1 166 Risk Ratio(M-H, Fixed, 95% CI) 0.88[0.49, 1.58]
4 Motivational interviewing (single) (MI-S) versus hepatitis health promotion (HHP)
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
63 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users: Coch...
38 / 51
4.1 Continuous outcomes 1   Mean Difference(IV, Fixed, 95% CI) Subtotals only
   4.1.1 Alcohol use as number of
standard drinks consumed per day
over the last 30 days 
1 155 Mean Difference(IV, Fixed, 95% CI) -0.10[-1.89, 1.69]
   4.1.2 Illicit drug use as frequency
of drug use (as measured by
Addiction Severity Index - ASI drug)
1 155 Mean Difference(IV, Fixed, 95% CI) 0.00[-0.03, 0.03]
   4.1.3 Illicit drug use as a
composite drug score
(frequency*severity for all drugs
taken)
1 157 Mean Difference(IV, Fixed, 95% CI) -0.10[-0.46, 0.26]
4.2 Dichotomous outcomes 1   Risk Ratio(M-H, Fixed, 95% CI) Subtotals only
   4.2.1 Alcohol use as greater than
50% reduction in number of standard
drinks consumed per day over the
last 30 days
1 177 Risk Ratio(M-H, Fixed, 95% CI) 0.92[0.68, 1.26]
   4.2.2 Alcohol abstinence as
abstinence from alcohol over the last
30 days
1 177 Risk Ratio(M-H, Fixed, 95% CI) 0.97[0.56, 1.67]
5 Brief motivational intervention (BMI) versu assessment only
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
5.1 Continuous outcomes 1   Mean Difference(IV, Fixed, 95% CI) Subtotals only
   5.1.1 Alcohol use as number of
days in the past 30 days with alcohol
use at 1 month
1 187 Mean Difference(IV, Fixed, 95% CI) -0.30[-3.38, 2.78]
   5.1.2 Alcohol use as number of
days in the past 30 days with alcohol
use at 6 months
1 187 Mean Difference(IV, Fixed, 95% CI) -1.50[-4.56, 1.56]
5.2 Dichotomous outcomes 1   Risk Ratio(M-H, Fixed, 95% CI) Subtotals only
   5.2.1 Alcohol use as 25%
reduction of drinking days in the past
30 days
1 187 Risk Ratio(M-H, Fixed, 95% CI) 1.23[0.96, 1.57]
   5.2.2 Alcohol use as 50%
reduction of drinking days in the past
30 days
1 187 Risk Ratio(M-H, Fixed, 95% CI) 1.27[0.96, 1.68]
   5.2.3 Alcohol use as 75%
reduction of drinking days in the past
30 days
1 187 Risk Ratio(M-H, Fixed, 95% CI) 1.21[0.84, 1.75]
   5.2.4 Alcohol use as 1 or more
drinking days' reduction in the past
30 days
1 187 Risk Ratio(M-H, Fixed, 95% CI) 1.12[0.91, 1.38]
   5.2.5 Alcohol use as 7 or more
drinking days' reduction in the past
30 days
1 187 Risk Ratio(M-H, Fixed, 95% CI) 1.67[1.08, 2.60]
Figures
Figure 1
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Caption
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figure 3
Caption
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included
studies.
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Appendices 
1 PubMed search strategy
MEDLINE (via PubMed)
Tuesday, November 22, 2011 (2656 hits):
Search terms to locate drug abuse:
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1. "Substance-Related Disorders"[MeSH]
2. addict*[tiab] OR overdose[tiab] OR intoxicat*[tiab] OR abstin*[tiab] OR abstain*[tiab] OR withdrawal*[tiab] OR abuse*[tiab]
OR use*[tiab] OR misuse[tiab] OR disorder*[tiab] OR dependen*[tiab]
3. #1 or #2
Search terms to identify drugs:
4. ''heroin"[mh] OR heroin[tiab]
5. narcotic*[tiab]
6. drug[tiab] OR polydrug[tiab] OR substance[tiab] OR opioid[tw] OR opiate[tw] OR hallucinogen[tiab] OR cocaine[tw] OR
benzodiazepine*[tw] OR amphetamine*[tw] OR "anti-anxiety-agents"[tiab] OR barbiturate*[tiab] OR "lysergic acid"[tiab] OR
ketamine[tiab] OR cannabis[tiab] OR marihuana[tiab] OR hashish[tiab] OR opium[tiab] OR inhalant*[tiab] OR solvent[tiab] OR
steroid*[tiab] OR methadone[tiab] OR morphine[tiab] OR ecstasy[tiab] OR MDMA[tiab]
7. ''Street Drugs"[MeSH]
8. ''Designer Drugs"[MeSH]
9. #4 or #5 or #6 or #7 or #8
Search terms to identify alcohol:
10. alcohol*[tiab]




15. #10 or #11 or #12 or #13 or #14
Search terms to locate interventions:
16. psychotherapy [MeSH]
17. incentive*[tiab] OR voucher[tiab] OR psychotherap*[tiab] OR psychosocial*[tiab] OR ''behaviour therapy'' [tiab] OR
''behavior therapy''[tiab] OR reinforcement[tiab] OR motivation*[tiab] OR contingent*[tiab] OR advice[tiab] OR








25. ''stress management training'' [tiab]







33. #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32
Search terms to locate randomised controlled trials
34. randomised controlled trial [pt]
35. controlled clinical trial [pt]
36. random*[tiab]
37. placebo [tiab]
38. drug therapy [sh]
39. trial [tiab]
40. groups [tiab]
41. #34 or #35 or #36 or #37 or #38 or #39 or #40
42. Animals [mh] NOT Humans [mh]
43. #41 NOT #42
44. #3 AND #9 AND ##15 AND #33 AND #43
2 CENTRAL (CLIB) search strategy
The Cochrane Library
Issue 11, Nov 2011 (1736 hits)
#1. MeSH descriptor Substance-Related Disorders explode all trees
#2. ((stimulant* or polydrug* or drug* or substance) near/3 (abuse* or abusing or depend* or addict* or disorder* or intoxicat*
or misus* or use* )):ti,ab
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#3. (#1 OR #2)
#4. (abuse* or abusing or depend* or addict* or depend* or overdos* or withdraw* or abstain* or abstinen* or disorder* or
intoxicat* or misus*):ti,ab,kw
#5. use*:ti,ab
#6. (#4 OR #5)
#7. MeSH descriptor Narcotics explode all trees
#8. (heroin or morphine* or diamorphine or diacetylmorphine or morfin* or narcotic* or methadone):ti,ab,kw
#9. MeSH descriptor Methadone explode all trees
#10. (Opioid* or opiate* or opium):ti,ab,kw
#11. MeSH descriptor Amphetamine explode all trees
#12. (amphetamine* or dextroamphetamine* or methamphetamine or Methylamphetamine*):ti,ab,kw
#13. MeSH descriptor Methamphetamine explode all trees
#14. (ecstasy or MDMA or hallucinogen*):ti,ab,kw
#15. MeSH descriptor Hallucinogens explode all trees
#16. MeSH descriptor Street Drugs explode all trees
#17. MeSH descriptor Cocaine explode all trees
#18. (crack or cocaine):ti,ab,kw
#19. MeSH descriptor Cannabis explode all trees
#20. (cannabis or marijuana or marihuana or Hashish):ti,ab,kw
#21. (Lysergic NEXT Acid):ti,ab,kw
#22. (LSD):ti,ab,kw
#23. (benzodiazepine* or barbiturate* or ketamine or solvent or inhalant):ti,ab,kw
#24. (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21
OR #22 OR #23)
#25. (#6 AND #24)
#26. (#3 OR #25)
#27. (alcohol*):ti,ab,kw
#28. (binge or drink*):ti,ab
#29. MeSH descriptor Drinking Behavior explode all trees
#30. MeSH descriptor Alcoholism explode all trees
#31. MeSH descriptor Alcoholic Intoxication explode all trees
#32. (#27 OR #28 OR #29 OR #30 OR #31)
#33. MeSH descriptor Psychotherapy explode all trees
#34. (psychotherap* or psychosocial or voucher or reinforcement or motivation* or contingent* or biofeedback or community
or stimulation or education* or counsel*):ti,ab,kw
#35. (social near/2 skill*):ti,ab
#36. (coping near/2 skill):ti,ab
#37. MeSH descriptor Counseling explode all trees
#38. (behavi* near/2 therap*):ti,ab
#39. MeSH descriptor Reinforcement (Psychology) explode all trees
#40. (brief near intervention):ti,ab
#41. (early near intervention):ti,ab
#42. (minimal near intervention):ti,ab
#43. (cognitive near therapy):ti,ab
#44. (family near therapy):ti,ab
#45. (stress near management near training):ti,ab
#46. (supportive near expressive near therapy):ti,ab
#47. MeSH descriptor Social Support explode all trees
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#48. MeSH descriptor Case Management explode all trees
#49. (self near control near training):ti,ab
#50. neurobehavioral*:ab,ti
#51. (#33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR
#47 OR #48 OR #49 OR #50)
#52. (#26 AND #32 AND #51)
#53. "(#26 AND #32 AND #51) in Cochrane Central Register of Controlled Trials"
3 EMBASE search strategy
EMBASE (via embase.com) 
Tuesday, November 22, 2011 (1717 hits)
#1. 'addiction'/exp
#2. dependen*:ab,ti OR addict*:ab,ti OR overdos*:ab,ti OR intoxicat*:ab,ti OR abstin*:ab,ti OR abstain:ab,ti OR
withdraw*:ab,ti OR abus*:ab,ti OR use*:ab,ti OR misus*:ab,ti OR disorder*:ab,ti
#3. #1 OR #2
#4. 'diamorphine'/exp
#5. diamorphine:ab,ti OR heroin:ab,ti OR narcotic*:ab,ti OR drug*:ab,ti OR polydrug:ab,ti OR substance:ab,ti OR opioid:ab,ti
OR opiate:ab,ti OR hallucinogen:ab,ti OR cocaine:ab,ti OR benzodiazepine:ab,ti OR amphetamine:ab,ti OR 'anti-anxiety-
agents':ab,ti OR barbiturate:ab,ti OR 'lysergic acid':ab,ti OR ketamine:ab,ti OR cannabis:ab,ti OR marihuana:ab,ti OR
marijuana:ab,ti OR hashish:ab,ti OR opium:ab,ti OR inhalant:ab,ti OR solvent:ab,ti OR steroid:ab,ti OR methadone:ab,ti OR
morphine:ab,ti OR ecstasy:ab,ti OR mdma:ab,ti
#6. 'designer drug'/exp
#7. 'street drug'/exp
#8. #5 OR #6 OR #7




#13. #9 OR #10 OR #11 OR #12
#14. 'psychotherapy'/exp
#15. incentive*:ab,ti OR voucher:ab,ti OR psychotherap*:ab,ti OR psychosocial*:ab,ti OR reinforcement:ab,ti OR
motivation*:ab,ti OR contingent*:ab,ti OR advice:ab,ti OR biofeedback:ab,ti OR community:ab,ti OR stimulation:ab,ti OR
education*:ab,ti
#16. 'behaviour therapy':ab,ti OR 'behavior therapy':ab,ti
#17. counsel*:ab,ti
#18. 'counseling'/exp 
#19. 'cognitive therapy':ab,ti OR 'family therapy':ab,ti OR 'social skill':ab,ti OR 'stress management training':ab,ti OR
'supportive expressive therapy':ab,ti






#26. #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR
#23 OR #24 OR #25
#27. 'crossover procedure'/exp 
#28. 'double blind procedure'/exp
#29. 'single blind procedure'/exp
#30. 'controlled clinical trial'/exp
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#31. 'clinical trial'/exp
#32. placebo:ab,ti OR 'double blind':ab,ti OR 'single blind':ab,ti OR assign*:ab,ti OR allocat*:ab,ti OR volunteer*:ab,ti
#33. random*:ab,ti OR factorial*:ab,ti OR crossover:ab,ti OR (cross:ab,ti AND over:ab,ti)
#34. 'randomized controlled trial'/exp
#35. #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34
#36. #3 AND #8 AND #13 AND #26 AND #35 AND [humans]/lim AND  [embase]/lim
4 CINAHL search strategy
CINAHL (via EBSCO)
Tuesday, November 22, 2011 (127 hits)
S01. MH "Substance Use Disorders"
S02. TX(drug N3 addict*) or TX(drug N3 dependen*) or TX(drug N3 abuse*) or TX(drug N3 misus*) or TX(drug N3 use*)
S03. TX(substance N3 addict*) or TX(substance N3 dependen*) or TX(substance N3 abuse*) or TX(substance N3 misus*)
S04. S1 or S2 or S3




S08. MH "Designer Drugs"
S09. TX(polydrug or opioid or opiate or opium or hallucinogen or cocaine or benzodiazepine* or amphetamine*or “anti-
anxiety-agents” or barbiturate* or “lysergic acid” or ketamine or cannabis or marihuana or hashish or inhalant* or solvent or
steroid* or methadone or morphine)
S10. TI ecstasy or TI mdma or AB ecstasy or AB mdma
S11. S6 or S7 or S8 or S9 or S10
S12. S5 and S11
S13. S4 or S12
S14. TI alcohol* or AB alcohol*
S15. TI drink* or TI binge or AB drink* or AB binge
S16. MH "Alcoholism"
S17. MH "Alcoholic Intoxication"
S18. (MH "Drinking Behavior+")
S19. S14 or S15 or S16 or S17 or S18
S20. MH "Clinical Trials+"
S21. PT Clinical trial
S22. TI clinic* N1 trial* or AB clinic* N1 trial*
S23. TI ( singl* or doubl* or trebl* or tripl* ) and TI ( blind* or mask* )
S24. AB ( singl* or doubl* or trebl* or tripl* ) and AB ( blind* or mask* )
S25. TI randomi?ed control* trial* or AB randomi?ed control* trial*
S26. MH "Random Assignment"
S27. TI random* allocat* or AB random* allocat*
S28. MH "Placebos"
S29. TI placebo* or AB placebo*
S30. MH "Quantitative Studies"
S31. S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30
S32. S13 and S19 and S31
S33. S13 and S19 and S31
Limiters - Exclude MEDLINE records; Human
5 PsycINFO search strategy
PsycINFO (via ProQuest) 
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Tuesday, November 22, 2011 (706 hits)
1. (all((TI,AB(psychotherap*) OR TI,AB(psychosocial*) OR TI,AB(“behaviour therapy”) OR TI,AB(“behavior therapy”) OR
TI,AB(reinforcement) OR TI,AB(motivation*) OR TI,AB(contingent*) OR TI,AB(advice) OR TI,AB(biofeedback) OR
TI,AB(community) OR TI,AB(stimulation) OR TI,AB(education*) OR SU("psychotherapy") OR (TI,AB(incentive*) OR
TI,AB(voucher)))
2. (TI,AB,IF(alcohol*) OR (TI,AB,IF(binge) OR TI,AB,IF(drink*)) OR SU(alcoholism) OR SU(''alcohol intoxication'') OR
SU("alcohol drinking patterns"))
3. ((IF(''heroin'') OR IF(''morphine'')) OR IF(''narcotics'') OR (TI,AB(drug) OR TI,AB(polydrug) OR TI,AB(substance) OR
TI,AB(opioid) OR TI,AB(opiate) OR TI,AB(''hallucinogenic drugs'') OR IF(''psychedelic drugs'') OR IF(''Lysergic Acid
Diethylamide'') OR TI,AB(LSD) OR TI,AB(cocaine) OR TI,AB(benzodiazepine*) OR TI,AB(''amphetamine'') OR TI,AB(''anti-
anxiety-agents'') OR TI,AB(barbiturate*) OR TI,AB(ketamine) OR TI,AB(''cannabis'') OR TI,AB(''marihuana'') OR
TI,AB(hashish) OR TI,AB(opium) OR TI,AB(''inhalant abuse'') OR TI,AB(solvent) OR TI,AB(steroid*) OR TI,AB(''methadone'')
OR TI,AB(ecstasy) OR TI,AB(''methylenedioxyamphetamine'')) OR (IF(street drug*) OR IF(designer drug*)))
4. (SU("drug abuse") OR (IF(addict* OR abus* OR dependen*) OR cabs(overdose) OR cabs(intoxicat*) OR cabs(abstin*) OR
cabs(abstain) OR cabs(withdrawal) OR cabs(abuse) OR cabs(use) OR cabs(misuse) OR cabs(disorder*) OR IF(''drug
addiction''))))
5. SU(treatment effectiveness evaluation)
6. SU(clinical trials)






13. TI,AB((singl* OR doubl* OR trebl* OR tripl*) W/3 (blind* OR mask* OR dummy))





19. 5 AND 6 AND 7 AND 8 AND 9 AND 10 AND 11 AND 12 AND 13 AND 14 AND 15 AND 16 AND 17 AND 18
20. 1 AND 2 AND 3 AND 4 AND 19
21. 20 AND (po.exact("human")






Low risk The investigators describe a random component in the sequence generation process such
as: random number table; computer random number generator; coin tossing; shuffling
cards or envelopes; throwing dice; drawing of lots; minimisation
  High risk The investigators describe a non-random component in the sequence generation process
such as: odd or even date of birth; date (or day) of admission; hospital or clinic record
number; alternation; judgement of the clinician; results of a laboratory test or a series of
tests; availability of the intervention





Low risk Investigators enrolling participants could not foresee assignment because one of the
following, or an equivalent method, was used to conceal allocation: central allocation
(including telephone, web-based, and pharmacy-controlled, randomisation); sequentially
numbered drug containers of identical appearance; sequentially numbered, opaque,
sealed envelopes
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  High risk Investigators enrolling participants could possibly foresee assignments because one of the
following method was used: open random allocation schedule (e.g. a list of random
numbers); assignment envelopes without appropriate safeguards (e.g. if envelopes were
unsealed or non­opaque or not sequentially numbered); alternation or rotation; date of
birth; case record number; any other explicitly unconcealed procedure
  Unclear riskInsufficient information to permit judgement of low or high risk This is usually the case if the
method of concealment is not described or not described in sufficient detail to allow a
definite judgement









No blinding of outcome assessment, but the review authors judge that the outcome
measurement is not likely to be influenced by lack of blinding
Blinding of outcome assessment ensured, and unlikely that the blinding could have been
broken
  High risk No blinding of outcome assessment, and the outcome measurement is likely to be
influenced by lack of blinding
Blinding of outcome assessment, but likely that the blinding could have been broken, and
the outcome measurement is likely to be influenced by lack of blinding












No missing outcome data
Reasons for missing outcome data unlikely to be related to true outcome (for survival data,
censoring unlikely to be introducing bias)
Missing outcome data balanced in numbers across intervention groups, with similar
reasons for missing data across groups
For dichotomous outcome data, the proportion of missing outcomes compared with
observed event risk not enough to have a clinically relevant impact on the intervention
effect estimate
For continuous outcome data, plausible effect size (difference in means or standardised
difference in means) among missing outcomes not enough to have a clinically relevant
impact on observed effect size
Missing data have been imputed using appropriate methods
All randomised patients are reported/analysed in the group they were allocated to by
randomisation irrespective of non-compliance and co-interventions (intention to treat)
  High risk Reason for missing outcome data likely to be related to true outcome, with either
imbalance in numbers or reasons for missing data across intervention groups
For dichotomous outcome data, the proportion of missing outcomes compared with
observed event risk enough to induce clinically relevant bias in intervention effect estimate
For continuous outcome data, plausible effect size (difference in means or standardised
difference in means) among missing outcomes enough to induce clinically relevant bias in
observed effect size
'As-treated' analysis done with substantial departure of the intervention received from that
assigned at randomisation
  Unclear riskInsufficient information to permit judgement of low or high risk (e.g. number randomised not
stated, no reasons for missing data provided; number of drop-out not reported for each
group)
Graphs
1 - Cognitive-behavioural coping skills training (CBT) versus 12-step facilitation (TSF)
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2 - Brief intervention (BI) versus treatment as usual
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3 - Motivational interviewing(group) (MI-G) versus hepatitis health promotion (HHP)
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4 - Motivational interviewing (single) (MI-S) versus hepatitis health promotion (HHP)
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5 - Brief motivational intervention (BMI) versu assessment only
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